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Résumé 
 
E. coli avec potentiel zoonotique pourrait éclore dans les réservoirs porcins et 
avicoles.  Cette étude consiste à examiner la présence de souches E. coli porteuses de 
gènes virulents associés aux STEC (E. coli producteurs de Shiga-toxines), EPEC (E. 
coli entéropathogène), et ExPEC (E. coli pathogène extra-intestinal) chez les porcs et 
volailles élevés au Vietnam.  Des prélèvements d’excréments et de carcasses ont été 
effectués dans des fermes et abattoirs porcins et avicoles sélectionnés où les animaux 
ont été suivis de l’élevage à l’abattage. Un total de 13,1% des souches, toutes sources 
confondues, ont été catégorisées comme potentiellement contaminées par ExPEC, 
possédant un ou plusieurs gènes de virulence iucD, tsh, papC et cnf.  Peu d’isolats 
d’autres pathotypes ont été observés. Tous les gènes de virulence ExPEC, à 
l’exception de cnf, ont été identifiés plus fréquemment dans les isolats de fèces et 
carcasses avicoles que dans les isolats porcins. Même constatation pour le groupe du 
phylogénétique D. Une multirésistance aux médicaments a été régulièrement 
observée chez les deux isolats ExPEC.  Les isolats de fèces de volailles ont souvent 
été associés à une résistance à l’acide nalidixique et à la ciprofloxacine (P<0.05), de 
même qu’au gène blaTEM, alors que les gènes qnr et aac(6’)-Ib ont peu été rencontrés 
des deux côtés. Cette étude démontre que les isolats ExPEC avicoles sont 
potentiellement plus pathogèniques que ceux porcins et que les isolats ExPEC de 
carcasses porcines et avicoles peuvent provenir de leurs excréments par la 
contamination associée au processus d'abattage. Ainsi, la volaille, particulièrement, 
serait un facteur de transmission de souches ExPEC zoonotiques. 
Mots clé : résistance antimicrobienne, gènes virulents, porcs et volailles, fermes, 
abattoirs, carcasses, ExPEC, PCR. 
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Summary 
 
Zoonotic potential pathogenic Escherichia coli could arise from poultry and pig 
reservoirs. The aim of this study is  to investigate the occurrence of E. coli strains 
carrying virulence genes associated with STEC (Shiga toxin-producing E. coli), 
EPEC (Enteropathogenic E. coli), and ExPEC (Extraintestinal pathogenic E. coli) in 
pigs and poultry on-farm and at abattoirs in Vietnam. Samples of feces and carcasses 
were collected at selected pig and poultry farms and abattoirs, in which animals were 
traced from farms to the abattoir. A total of 13.1% strains from all sources were 
classified as potential ExPEC, possessing one or more virulence genes iucD, tsh, 
papC and cnf.  Few isolates of other pathotypes were observed. All ExPEC virulence 
genes, except cnf, were more frequently found in isolates from poultry than in 
isolates from pigs. A higher proportion of ExPEC isolates belonging to phylogenetic 
group D was observed in poultry. Multi-drug resistance was frequently observed in 
ExPEC isolates from both pigs and poultry. Nalidixic acid and ciprofloxacin 
resistance were significantly associated with poultry feces isolates (P<0.05). blaTEM 
gene was more frequently associated with poultry isolates, whereas qnr and aac(6’)-
Ib genes were present at low prevalence in pig and poultry isolates. This study 
demonstrates that poultry ExPEC isolates are potentially more pathogenic than pig 
ExPEC isolates, and ExPEC isolates in pig and poultry carcasses may originate from 
pig and poultry feces, due to contamination associated to slaughtering process. Thus, 
meats particularly from poultry, might be a vehicle for transmission of zoonotic 
ExPEC strains. 
Key words: antimicrobial resistance, virulence genes, pigs and poultry, farms, 
abattoirs, carcasses, ExPEC, PCR.  
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INTRODUCTION 
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Escherichia coli (E. coli) is a common micro-organism in the gastrointestinal tract of 
humans and animals. Most E. coli are harmless; however, some are pathogenic and 
can cause disease in humans and animals (Johnson, 2003; Kaper, Nataro, & Mobley, 
2004). From a genetic and clinical perspective, E. coli strains of biological 
significance to humans can be broadly categorized as (1) commensal strains, (2) 
intestinal pathogenic (i.e. enteric or diarrheagenic) strains, and (3) extraintestinal 
pathogenic E. coli (ExPEC) strains (Russo & Johnson, 2003). In addition, E. coli are 
classified into phylogenetic groups A, B1, B2, and D (Clermont et al., 2000). 
Intestinal pathogenic E. coli such as enteropathogenic E. coli (EPEC) and Shiga 
toxin-producing E. coli (STEC) may cause gastrointestinal disease, mostly consisting 
of more or less severe diarrhea, in humans and animals. EPEC is considered as one 
of leading causes of infant diarrhea in developing countries, whereas STEC is one of 
the most common pathogens associated with outbreaks of foodborne illness, causing 
bloody diarrhea and hemolytic-uremic syndrome, particularly in North America, 
Japan and European countries (Kaper et al., 2004). ExPEC strains do not produce 
enteric disease; however, they may  cause diverse extraintestinal infections, including 
urinary tract infections (UTIs), meningitis and septicemia, in both humans and 
animals (Smith et al, 2007). ExPEC express a variety of virulence-associated genes 
instead of having a common virulence mechanism (Johnson et al, 1991, Smith et al 
2007). Typical virulence factors of ExPEC include diverse adhesins, siderophores for 
iron acquisition, capsules, toxins, proteases, invasins, and serum resistance proteins 
(Kaper et al, 2004). ExPEC isolates from urinary tract infections in humans most 
commonly belong to phylogenetic groups B2 or D. 
Animal-derived raw foods are commonly contaminated with E. coli and have long 
been known as an important vehicle for transmitting diarrheagenic E. coli, but their 
role in spreading ExPEC has not been explored extensively (Xia et al., 2011). ExPEC 
can asymptomatically colonize the animal and human intestinal tract, thus could be 
transmitted to humans through food consumption (Bélanger et al., 2011; Fairbrother 
& Nadeau, 2006). Recent studies indicate retail meat may be an important vehicle for 
transmission of ExPEC that share characteristics with human clinical ExPEC strains 
(Johnson et al., 2003a, 2005b; Jakobsen et al., 2010; Vincent et al., 2010). In 
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addition, it was suggested that meat consumption was epidemiologically associated 
with infection by antimicrobial-resistant ExPEC that causes UTI (Johnson, et al., 
2005b). These findings suggest the hypothesis that potentially zoonotic ExPEC in 
contaminated meat could arise from poultry and pig reservoirs.  
There have been no published studies on the prevalence of STEC, EPEC, and ExPEC 
in pigs and poultry on-farm in Vietnam. In addition, few current data are available on 
the prevalence of antimicrobial-resistant E. coli from animals at the farm level and 
from carcasses in abattoirs in this country. The aim of this study is to investigate the 
prevalence of E. coli strains carrying virulence genes associated with STEC, EPEC, 
and ExPEC in pigs and poultry on farms and at abattoirs, and to characterize these 
potentially pathogenic strains for phylogenetic group and antimicrobial resistance 
profile.  
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1. Classification of E. coli 
1.1. Commensal E. coli 
Commensal E. coli constitute part of the gastrointestinal microflora in humans, 
mammals, and birds. The commensal strains are generally benign, do not cause 
intestinal tract disease, and can be beneficial to the host (Russo and Johnson, 2003). 
However, commensal strains may cause illness if the host is compromised 
immunologically or medically (Picard et al., 1999; Russo and Johnson, 2003). 
Commensal E. coli generally lack the specialized virulence traits that enable 
intestinal and extraintestinal E. coli to cause disease within or outside the 
gastrointestinal tract, respectively. However, commensal E. coli can participate in 
extraintestinal infections when an aggravating factor is present, such as a foreign 
body (e.g. urinary catheter), host compromise (e.g. local anatomical or functional 
abnormalities such as urinary or biliary tract obstruction, or immunocompromise), or 
a high or a mixed bacterial species inoculum (e.g. with fecal contamination of the 
peritoneal cavity). 
Generally, human commensal E. coli strains belong to phylogenetic groups A and B1 
and typically lack the specialized virulence determinants found in pathogenic strains 
that cause intestinal or extraintestinal diseases (Picard et al., 1999; Russo and 
Johnson, 2000). 
1.2. Intestinal pathogenic E. coli 
Intestinal pathogenic E. coli have evolved a special ability to cause gastrointestinal 
disease, mostly consisting of more or less severe diarrhea in humans and animals. 
Intestinal pathogenic E. coli are currently classified in six categories based on 
virulence attributes that help bacteria to cause diseases, including: enteropathogenic 
E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely 
adherent E. coli (DAEC) (Kaper et al., 2004). EHEC is also known as the pathogenic 
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subgroup of Shiga toxin-producing E. coli (STEC) that cause hemorrhagic colitis and 
hemolytic uremic syndrome (HUS) (Nataro & Kaper, 1998)  
1.2.1.Enteropathogenic E. coli (EPEC) 
EPEC is considered as one of leading causes of diarrhea in developing countries 
(Kaper et al, 2004). The central mechanism of EPEC pathogenesis is a lesion called 
attaching and effacing (A/E), which is characterized by microvilli destruction, 
intimate adherence of bacteria to the intestinal epithelium, pedestal formation, and 
aggregation of polarized actin and other elements of the cytoskeleton at sites of 
bacterial attachment (Kaper et al., 2004). Ability to produce A/E lesions has also 
been detected in strains of Shiga toxin–producing E. coli  (Nataro & Kaper, 1998). 
The genetic determinants for the production of A/E lesions are located on the locus 
of enterocyte effacement (LEE), a pathogenicity island that contains the genes 
encoding intimin, a type III secretion system, a number of secreted (Esp) proteins, 
and the translocated intimin receptor named Tir.  Intimin, a 94-kDa outer membrane 
protein encoded by the eae gene, is responsible for the intimate adherence between 
bacteria and enterocyte membranes. The Esp molecules (EspA, B, and D) are 
involved in the formation of a translocon that delivers effector molecules to the host 
cell and disrupts the cytoskeleton, subverting the host cell functions. Tir, which is 
one of the EPEC translocated proteins, is inserted into the host cell membrane, where 
it acts as a receptor to intimin (Kaper et al., 2004; Trabulsi et al., 2002) 
Typical EPEC strains possess a plasmid of 70–100 kb called the EAF (EPEC 
adherence factor) plasmid, whereas atypical EPEC do not contain the EAF plasmid 
(Trabulsi et al., 2002). This plasmid encodes a type IV pilus called the bundle-
forming pilus (BFP), which mediates interbacterial adherence and possibly adherence 
to epithelial cells (Kaper et al., 2004). Thus far, typical EPEC strains are identified 
by the presence of both eae and bfp, whereas atypical EPEC strains have been 
defined as those which possess only eae (Hernandeset al., 2009). Atypical EPEC 
serotypes have been isolated from different animal species suggesting that atypical 
EPEC may be a potential zoonotic cause of human diarrhea (Trabulsi et al, 2002). 
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Atypical enteropathogenic E. coli (EPEC) were identified among E. coli isolates 
from pork, indicating that pigs may also be potential reservoirs for the pathogen (Xia 
et al., 2010). Analysis of phenotypic and genotypic markers of atypical EPEC 
isolated from diarrheic and non-diarrheic dogs demonstrated that isolates of 
serotypes O4:H16 and O51:H40 were similar to those found in human disease 
(Almeida et al., 2012). 
1.2.2. Shiga toxin-producing E. coli (STEC) 
Shiga toxin-producing E. coli refers to those strains of E. coli that produce at least 
one member of a class of potent cytotoxins called Shiga toxin, also called 
verocytotoxin (Gyles, 2007). STEC have been characterized by a variety of methods, 
including serotyping.  Isolates of O157:H7 serotype are the most common STEC 
pathogens associated with outbreaks of foodborne illness in North America, but 
several other serotypes, particularly those of the O26 and O111 serogroups, can also 
cause disease and are more important than O157:H7 in other countries (Kaper et al., 
2004). It is well established that cattle are a major reservoir of STEC O157:H7 in 
North America but in countries such as Australia, sheep are of greater significance 
(Gyles, 2007).   
Shiga toxin is the key virulence factor in STEC diseases. Currently, Shiga-like toxins 
are categorized into two immunologically distinct groups: Stx1 and Stx2, which 
show approximately 55% sequence homology (Kaper et al., 2004). Stx1 and Stx2 
share a similar function and have the same genetic operon structure, encoding an A 
(enzymatic toxin) and a B (cell receptor binding) subunit. Stx1 and Stx2 are further 
subdivided into distinct genetic variants which differ in their biological activity and 
association with disease (Gyles, 2007). 
Adherence to intestinal epithelial cells is an early feature of STEC infection and two 
patterns of attachment and interaction have been observed, associated with eae-
positive and eae-negative STEC isolates. The eae-positive STEC possess a 
pathogenicity island called the locus of enterocyte effacement (LEE), which encodes 
the bacterial proteins necessary for formation of the AE lesion (Kaper et al., 2004; 
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Nataro & Kaper, 1998). The combined presence of the eae and stx2 genes has been 
indicated as an important predictor of HUS (Ethelberg et al., 2004). 
1.2.3. Enterotoxigenic E. coli (ETEC) 
ETEC is a pervasive cause of diarrhea in children and travellers in developing 
countries (Kaper et al, 2004). ETEC produce one or both of two enterotoxins, heat-
labile enterotoxin (LT) and heat-stable enterotoxin (ST) which are major virulence 
factors. LT was found to be very similar physiologically, structurally, and 
antigenically to cholera toxin (CT) and to have a similar mode of action 
(Svennerholm, 2011). The molecular mass (84 kDa) and the subunit structure of the 
two toxins were essentially identical, with an active (A) subunit surrounded by five 
identical binding (B) subunits. LT can stimulate prostaglandin synthesis and 
stimulate the enteric nervous system; both of these activities can also lead to 
stimulation of secretion and inhibition of absorption (Kaper et al, 2004). STs are low-
molecular-weight peptides, that are classified into two unrelated classes — STa and 
STb — which differ in both structure and mechanism of action. Only toxins of the 
STa class have been associated with human disease whereas the STb toxin is 
associated with animal disease (Kaper et al, 2004). 
Other important virulence factors in ETEC include one or more colonization factors 
(CFs), which usually are fimbriae. More than 25 CFs have been recognized on 
human ETEC so far, and additional ones are likely to be recognized (Svennerholm, 
2011). The CFs promote colonization of ETEC in the small bowel, thus allowing 
expression of either or both LT and ST in close proximity to the intestinal epithelium 
(Quadri et al., 2005). ETEC are also an important cause of diarrhoeal disease in 
animals and these animal strains express fimbrial intestinal colonization factors, such 
as K88 and K99, which are not found in human ETEC strains.(Kaper et al, 2004) 
1.2.4. Enteroaggregative E. coli (EAEC) 
EAEC is an emerging pathogen which is increasingly recognized as a cause of 
persistent diarrhea in adults and children. EAEC are characterized by the ability to 
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aggregate intimately with each other, adhere to human HEp-2 cells, and also attach to 
abiotic surfaces when grown in tissue culture plates  (Okhuysen & Dupont, 2010).  
EAEC pathogenesis is determined by the organism's ability to adhere to intestinal 
cells, produce enterotoxins and cytotoxins, and induce inflammation.  A number of 
studies described several virulence factors associated with EAEC pathogenesis. 
These are (i) heat stable toxin-1 (EAST-1), (ii) aggregative adherence fimbriae I and 
II (AAF/I and AAF/II) and AAF/III. In addition, different pathogenicity islands have 
been identified within the EAEC group, including Shigella she pathogenicity island, 
containing enterotoxin and mucinase genes and Yersinia high-pathogenicity island, 
containing the yersiniabactin siderophore gene (Weintraub, 2007)  
1.3. Extraintestinal pathogenic E. coli (ExPEC) 
E. coli strains that induce extraintestinal diseases are termed extraintestinal 
pathogenic E. coli (ExPEC) (Russo and Johnson, 2000). In humans, ExPEC strains 
are often found in the normal intestinal flora and do not cause gastroenteritis. ExPEC 
strains are phylogenetically and epidemiologically distinct from intestinal pathogenic 
strains. They do not produce enteric disease; however, they can asymptomatically 
colonize the human intestinal tract and may be the predominant E. coli strains in 20% 
of normal individuals (Johnson and Russo, 2002; Russo and Johnson, 2000, 2003). 
ExPEC may cause diverse infections in both humans and animals, including urinary 
tract infections (UTIs), meningitis and septicemia (Smith et al, 2007). The sub-set of 
ExPEC causing UTI has been designated uropathogenic E. coli (UPEC). 
Most of the human ExPEC strains are found in the B2 and D phylogenetic groups 
and have acquired various virulence genes such as genes encoding attachment factors 
(pap, sfa, and afa), transmembrane protein involved in neonatal meningitis (ibe10), 
and alpha-hemolysin (hly) that allow them to induce extraintestinal infections in both 
normal and compromised hosts (Picard et al., 1999). The majority of the virulence 
factors present in ExPEC strains are distinct from those found in the intestinal 
pathogenic strains; Russo and Johnson, 2000, 2003).  
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ExPEC were defined by Johnson et al. as E. coli isolates containing two or more of 
the following virulence markers as determined by multiplex PCR: papA (P fimbriae 
structural subunit) and/or papC (P fimbriae assembly), sfa/foc(S and F1C fimbriae 
subunits), afa/dra(Dr-antigen-binding adhesins), kpsMTII (group 2 capsular 
polysaccharide units), and iutA (aerobactin receptor) (Johnson et al., 2003a). Other 
virulence markers are associated with ExPEC status, including fimH (type I 
fimbriae), ibe (outer membrane protein promoting invasion), and hly (hemolysin) 
(Kaper et al, 2004). 
2. Diseases caused by ExPEC in humans 
2.1. Urinary tract infections 
Extraintestinal pathogenic E. coli are a frequent cause of urinary tract infections 
(UTIs), which are among the most common bacterial infections found in humans 
(Johnson and Russo, 2002, 2005). In fact, UTIs are a heterogeneous group of 
disorders, which are classified by the site of infection, the bladder (cystitis), kidney 
(pyelonephritis) and urine (bacteriuria) (Foxman, 2002). Risks of UTIs are increased 
in specific groups including infants, pregnant women, the elderly and compromised 
patients (Foxman, 2002).  
Since the major means of transmission of UTI-causing ExPEC to the urinary tract is 
the ascending route from the fecal site into the bladder (Smith et al., 2007), the cause 
of ExPEC contamination in human has been debated. Johnson et al. indicate that 
meats, particularly poultry, can be an important source of ExPEC contamination 
(Johnson et al., 2003a, 2005a, 2005b).  
Treatment of UTIs usually consists of administration of antimicrobials, including 
beta-lactams, quinolones, trimethoprim in combination with sulfamethoxazole, and 
nitrofuranes (Wagenlehner et al., 2005). Notably, resistance of E. coli to commonly 
prescribed antimicrobial agents used in the treatment of UTIs has been significantly 
increasing (Smith et al., 2007). 
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2.2. Neonatal meningitis 
Bacterial neonatal meningitis is an inflammation of the membranes of the brain or 
spinal cord and consists of a purulent exudate of the membranes, perivascular in-
flammation, and brain edema. In the United States, more than 50% of cases of 
neonatal meningitis caused by Gram-negative enteric organisms were due to ExPEC, 
and approximately 80% of these cases were caused by strains carrying the K1 
capsular antigen (Pong and Bradley, 1999). 
The pathogenesis of ExPEC-induced neonatal meningitis occurs in several steps: 
bacteremia, binding of bacteria to the surface of brain microvascular endothelial 
cells, bacterial invasion of brain microvascular endothelial cells, and invasion of the 
meninges (membranes that surround the brain and spinal cord) and the central 
nervous system (Smith et al., 2007).  
Many of the virulence genes associated with ExPEC neonatal meningitis strains are 
present on pathogenicity islands (PAIs) (Bonacorsi et al., 2003). For example, the 
genes involved in facilitating blood-brain barrier penetration sfaS (fimbrial adhesin 
S), ibeA (invasin IbeA) and cnf1 (cytotoxic necrotizing factor) are located on PAIs 
(Bonacorsi et al., 2003). 
Holt et al. reported that the most common antimicrobial regimes used for neonatal 
meningitis treatment based on third generation cephalosporins such as cefotaxime in 
a combination with a penicillin or ampicillin with or without an aminoglycoside 
(Holt et al., 2001). The use of third generation cephalosporins decreased mortality 
but not morbidity (Harvey et al., 1999). 
2.3. Sepsis 
Sepsis can be caused by a microbial infection that originates from the kidneys (UTI), 
bowel (peritonitis), skin (cellulitis), or lungs (pneumonia). Russo and Johnson 
estimated that E. coli is the cause of 17% of the cases of severe sepsis (dysfunction 
of at least one organ system) in the United States (Russo and Johnson, 2003). They 
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estimated there were 127,500 cases of E. coli-induced severe sepsis, with 40,000 
deaths, in 2001; the mortality rate was approximately 30%.  
Individuals at the extremes of age are the most susceptible to bacterial-induced, 
community acquired septicemia; E. coli was found to be the most frequent cause of 
septicemia in infants up to 1 year of age and in individuals aged 65 or greater in 
North America (Diekema et al., 2002). Putative virulence factors for septicemia-
inducing strains of E. coli serogroups O2 and O78 include iron uptake systems 
(aerobactin, yersiniabactin, and IroN receptor), serum resistance, and adhesins (type 
1 fimbriae, curli, and P fimbriae). Non-fimbrial adhesins were present only in strains 
of serotype O78, and the K1 capsule was present only in O2 (Mokady et al., 2005).  
Hyde et al. noted that among the infants with early-onset sepsis, the proportion of E. 
coli infections that were resistant to ampicillin increased during the surveillance 
period (1998-2000) and mortality was higher with ampicillin-resistant E coli strains 
than with ampicillin-sensitive strains (Hyde et al., 2002).  
3. Virulence factors of pathogenic E. coli  
ExPEC strains have acquired genes encoding diverse extraintestinal virulence factors 
that enable them to cause infections outside of the gastrointestinal tract. 
Characteristic virulence traits that are present in most ExPEC include various 
adhesins (e.g. P and type I fimbriae), factors to avoid or subvert host defense systems 
(e.g. capsule, lipopolysaccharide), mechanisms for nutrient acquisition (e.g. 
siderophores), and toxins (e.g. hemolysin, cytotoxic necrotizing factor 1). 
3.1. Adhesins  
The adherence step contributes to extra intestinal virulence by promoting 
colonization and by facilitating bacterial interactions with host cells and matrix 
elements. Most E. coli adhesins are fimbrial (ie, discrete hair-like structures), but 
some are amorphous fibers or are capsule-like. Irrespective of morphology, most 
adhesins contain defined molecular regions that interact with specific host receptor 
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epitopes in a lock-and-key or lectin-like fashion (Johnson, 2003). The diverse 
adhesins of ExPEC are categorized primarily according to receptor specificity. The 
broadest functional division is between mannose-sensitive and mannose-resistant 
adhesins, reflecting the early observation that mannose blocks adherence for a subset 
of E. coli isolates that attaches to erythrocytes or epithelial cells (Johnson, 1991).  
3.1.1. Type 1 fimbriae 
Type 1 fimbriae are non-flagellar, filamentous appendages of bacteria, were 
classified into type I depending on haemagglutination and sensitivity activity with D-
mannose (Antao et al., 2009) 
Type 1 fimbriae are produced by more than 80% of all UPEC (Kucheria et al., 2005). 
The role of type 1 fimbriae in attachment of UPEC strains to host cells was 
demonstrated through in vitro and animal studies. Type 1-fimbriae mediated for 
specific binding of one E. coli strain to monkey kidney cells (Salit & Gotschlich, 
1977). Further research showed that type 1-fimbriae accounted for binding of E. coli 
strains to human urinary tract epithelial cells (Eden & Hansson, 1978).  
Type 1 fimbriae are encoded by the chromosomally located fim gene cluster, 
including genes for a structural subunit (FimA), an adhesin (FimH) andseveral 
accessory proteins involved in subunit transport and assembly, and regulatory 
proteins (Connell et al, 1996). FimH was found to be the gene responsible for the 
monomannose-containing receptors shown to be adaptive for UPEC which results in 
increased adhesion to vaginal epithelial cells (Antao et al., 2009). 
Type 1 fimbriae also play an important role in the infection process is the adherence 
of APEC to the epithelium of the trachea. This fimbriae in colibacillosis has been 
associated with mucus adherence, colonization of the trachea and the intestinal tract, 
and interactions with lung epithelial cells (de Pace et al., 2010) 
3.1.2. P fimbriae 
The P fimbriae family is the best known group of mannose-resistant adhesins, so 
named because of their binding specificity for the Gal(α 1-4) Gal- β disaccharide 
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galabiose, which is present in the antigens of the human P blood system (Johnson, 
2003). P fimbriae are important in the pathogenesis of UTI, primarily because they 
mediate Gal-Gal-specific bacterial adherence to epithelial cells within the human 
urinary tract, thereby permitting bacterial colonization and stimulating inflammation 
(Johnson, 1991).  
P fimbriae are composed of different polymerized subunits, with one major subunit, 
PapA, constituting the bulk of the fimbria. Three minor adherence-related fimbrial 
subunits (PapE, PapF, and PapG) are present in minor amounts at the fimbrial tips. 
These fimbrial proteins, as well as a number of accessory proteins, are encoded by a 
chromosomal gene cluster termed pap or pyelonephritis-associated fimbriae genes 
since these were typical of strains isolated from human urinary tract infections 
(Johnson, 1991). The adhesion of the fimbriae is conferred by the adhesin papG 
located at the distal end fimbriae. There are three alleles of adhesins papG (I, II, and 
III). Molecular epidemiological studies have shown that allele III of PapG is usually 
the predominant variant among E. coli isolates from women and children with 
cystitis, whereas the PapGII variant is associated with pyelonephritis in humans ( 
Johnson et al., 2000). Several other proteins are important in P-fimbrial synthesis. 
PapD is present in the periplasmic space and may complex with fimbrial subunits, 
stabilizing them during translocation across the periplasmic space to the outer 
membrane prior to assembly. PapC assists in the transport of subunits out of the cell 
and in their assembly into complete fimbriae (Johnson, 1991). The papC gene was 
observed at a high prevalence among E. coli strains associated with pyelonephritis, as 
determined by PCR (Le Bouguenec et al, 1992). 
The P fimbriae are not restricted to uropathogenic E. coli (UPEC) causing UTI and 
newborn meningitis-causing E. coli (NMEC), but are also prevalent in avian 
pathogenic E. coli (APEC) strains. In poultry, P fimbriae are primarily associated 
with colibacillosis strains, but P fimbriae are also found in healthy poultry. PapC has 
been found at a low prevalence in E. coli from healthy chickens in Denmark 
(Jakobsen et al., 2010), whereas the prevalence of papC in APEC strains was greater 
than 20% (Ewers et al., 2007; Rodriguez-Siek et al., 2005). Until now, studies on the 
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frequency of P fimbriae in healthy pigs are scarce. However, some previous studies 
have suggested that P fimbriae-positive E. coli are more frequent in diseased pigs 
than healthy pigs (Jakobsen et al., 2010; Tan et al., 2012). 
3.1.3.Temperature sensitive hemagglutinin 
The mannose-resistant haemagglutinin of an avian pathogenic E. coli (APEC) isolate, 
which was best expressed at low temperatures, was first reported in 1994 (Provence 
& Curtiss, 1994). This temperature-dependent haemagglutination phenotype was 
termed Tsh for temperature sensitive haemagglutinin (Provence & Curtiss, 1994). 
Tsh and Tsh/Pap (P fimbriae)/ Iuc (aerobactin) pathotypes were suggested as 
important virulence factors of APEC (Ngeleka, et al., 2002). 
Tsh is synthesized as a 140-kDa precursor protein, whose processing results in a 106-
kDa passenger domain (Tshs) and a 33-kDa β-domain (Tshβ). The presence of a 
conserved 7-amino-acid serine protease motif within Tshs classifies the protein in a 
subfamily of autotransporters, known as serine protease autotransporters of the 
Enterobacteriaceae (Kostakioti & Stathopoulos, 2004). The passenger domain 
(Tshs)  is secreted into the extracellular environment, being temporarily in the outer 
membrane of the bacteria where it is capable of adhering to red blood cells, 
hemoglobin, and the extracellular matrix proteins fibronectin (Antao et al., 2009; 
Kostakioti & Stathopoulos, 2004)  
Tsh is encoded by the gene tsh which is located on a ColV-type plasmid in many of 
the APEC strains. It has also been shown that tsh is more frequently observed in 
high-lethality isolates than in low-lethality isolates among APEC (Dozois et al., 
2000). In another study, it was shown that the tsh gene was present in more than 50% 
of APEC, 4.5% UPEC and 11.5% NMEC isolates tested (Ewers et al., 2007). In pigs, 
tsh was found significantly more frequently in highly virulent ExPEC strains 
belonging to group B2, which might indicate that tsh is involved in the pathogenic 
mechanisms of ExPEC (Picard et al., 1999; Tan et al., 2012). 
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3.2. Capsules (K antigen) 
Over 80 polysaccharide capsules (K antigen) have been described in E. coli (Orskov 
& Orskov, 1992). The capsules of most ExPEC strains belong to group 2 and 3 
polysaccharides which are characterized by low-molecular-weight and high-charge 
density ( Johnson, 1991;  Johnson & O'Bryan, 2004). The capsule protects ExPEC 
bacteria against phagocytosis and complement-mediated killing, thereby contributing 
to extraintestinal virulence (Burns & Hull, 1999; Russo, Liang, & Cross, 1994). K1 
capsule is the most commonly encountered capsular type among both urinary and 
fecal strains in humans ( Johnson, 1991). APEC strains possessing the K1 capsule 
also showed greater resistance to serum and ability to colonize the internal organs in 
poultry than K1-negative mutants (Mellata et al., 2003). 
Group 2 and group 3 capsules are encoded by kps operons which share moderately to 
highly conserved regions (e.g., kpsDMTE) encoding transport and assembly 
functions. Therefore, Johnson & O'Bryan developed a rapid technique for detection 
of K antigen in E. coli based on PCR amplification of the kpsM gene (Johnson & 
O'Bryan, 2004). The kpsM has been designated as one of virulence markers for 
identification of ExPEC in epidemiological studies (Johnson et al., 2005b).  
3.3. Lipopolysaccharide 
Lipopolysaccharide (LPS) is a structural component of the outer membrane of E. coli 
(Johnson, 1991). LPS, also known as endotoxin, consists of three components: the 
hydrophobic membrane anchor lipid A region, which is associated with the toxicity 
of the LPS and is well conserved among Gram-negative bacteria, the distal O-antigen 
polysaccharide region that is exposed to the surface and the core polysaccharide 
region that connects the two LPS components. The lipid A is largely responsible for 
stimulation of the innate immune system (DebRoyet et al., 2011). LPS is recognized 
by the Toll-like receptor 4 (TLR4) present on the surface of monocytes, 
macrophages, neutrophils and dendritic cells, cells of the innate immune system 
(Johnson, 2003). O antigens may contribute to the virulence of the organism, since 
certain O groups are associated with with specific diseases (DebRoy et al., 2011).  A 
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study on E. coli O18:K1 mutants lacking either the lipopolysaccharide O antigen 
showed that loss of the O antigen resulted in the strain becoming more sensitive to 
the bactericidal effects of the classical complement pathway (Pluschke et al., 1983).  
3.4. Iron acquisition systems 
 
Uptake of iron in Gram-negative bacteria is achieved primarily through the synthesis, 
export, and uptake of small iron-chelating molecules termed siderophores. 
Recognized siderophore systems include the catecholates enterobactin, salmochelin, 
the hydroxamate aerobactin, and yersiniabactin (Henderson et al., 2009;  Johnson, 
2003). Enterobactin is efficient at sequestering iron in vitro; however, it is less 
effective than aerobactin and salmochelin in competing for iron during infection, as it 
is inhibited by serum albumin and specifically binds to the host innate defense 
protein neutrophil lipocalin (Caza et al., 2008). 
The salmochelin-encoding system comprised of two divergently transcribed sets of 
genes, iroBCDE encoding the enzymes accounting for salmochelins production, and 
iroN encoding the outer membrane siderophore receptor. The specific roles of 
iroBCDE genes in salmochelins production as well as in contribution to APEC 
virulence have been identified (Caza et al., 2008). The iroN gene did not effect 
salmochelin production, however, it was required for the colonization of 
uropathogenic ExPEC (Russo et al., 2002), and the bacteremic step of E. coli 
neonatal meningitis (Negre et al., 2004). 
The aerobactin system is encoded by a five-genes operon, with four genes iucABCD 
encoding the enzymes needed for aerobactin synthesis and a fifth gene iutA encoding 
the outer membrane receptor protein. In E. coli, this operon is found both on 
plasmids and on the bacterial chromosome, with the chromosomal location 
predominating among human clinical isolates (Johnson, 1991). Due to the high 
prevalence of aerobactin-encoding genes among isolates from poultry with  
colibacillosis, the iucD gene was selected as one of virulence markers  for  the  rapid 
detection  and  characterization of  APEC (Ewers et al., 2005). 
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3.5. Cytotoxin:  
3.5.1.Hemolysin 
There are two common types of this toxin, α-haemolysin and β-haemolysin. The α -
haemolysin is commonly produced by strains isolated from cases of human UTI and 
other extra-intestinal infections. It is a heat-labile extracellular protein and its 
production can be plasmid or chromosomally determined. It is a pore forming 
cytolysin, and lyses erythrocytes by causing dissipation of transmembrane ion 
gradients. β-haemolysin is a cell associated haemolysin with a similar range of 
haemolytic activity ( Johnson, 1991). 
In addition to lysing erythrocytes, hemolysin is toxic to a range of host cells, 
probably contributing to inflammation, tissue injury, and impaired host defenses.  
Hemolysin production is encoded by a four-gene operon termed hly ( Johnson, 1991). 
Plasmid and chromosomal hly regions differ with respect to flanking and regulatory 
sequences and to the precise sequence of hlyA, the gene encoding the structural 
hemolysin protein. 
3.5.2 Cytotoxic necrotizing factor 
 
Cytotoxic necrotizing factor type 1 (CNF1), presents in certain diarrheagenic E. coli 
and UPEC, is a member of a family of bacterial toxins that target the Rho family of 
small GTP-binding proteins in mammalian cells (Johnson, 1991). The role of CNF1 
in the pathogenesis of UPEC-mediated urinary tract infection has been demonstrated 
in several studies.  In a mouse model of ascending urinary tract infection, a CNF1-
expressing UPEC, compared to its isogenic cnf1 mutant, caused a greater acute 
inflammatory response in the bladder, colonized the bladder more extensively in a 
coinfection experiment, and survived better when coincubated with human 
neutrophils (Rippere-Lampe et al., 2001). Epidemiological data showed that cnf1 
gene is significantly associated with clinical strains related to cystitis, pyelonephritis 
and prostatitis in humans (Yamamoto, 2007). Strains of UPEC that produce CNF1 
also often produce two established urovirulence determinants, α-hemolysin and P 
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fimbriae. The cnf1 gene encoding cytotoxic necrotizing factor and the genes 
encoding these other virulence factors are typically linked on the same pathogenicity 
island in certain UPEC strains (Mills et al,, 2000). 
4. Association among virulence factors and phylogenetic groups 
4.1. Associations among virulence factors 
Although  several important  ExPEC  virulence  factors  and  their  role  during  
pathogenesis  have  been  described  (Johnson, 1991; Smith et al., 2007), many  
ExPEC  cannot  be  unambiguously  distinguished  from  commensal  E.  coli based  
on  a  set  of  discriminatory virulence  factors  (Kohler & Dobrindt, 2011).  
Nevertheless,  ExPEC  classification  has been  proposed  based on  the  detection  of 
two  virulence-associated  genes   typical  of  the  specific  pathotype  (Johnson  and  
Russo,  2005),  and  two  virulence-associated  genes  for  non-host samples  such as  
food  samples  (Johnson  et  al.,  2005b). 
Certain VFs commonly occur together in patterns suggesting either co-selection or 
direct genetic linkage. A major virulence pattern, which was characterized by the 
presence of F1 variant fimbriae; S fimbriae; IbeA; and the aerobactin system was 
identified in 75% of the O18:K1 ExPEC isolates of human origin and avian origin 
(Moulin-Schouleur et al., 2006). Chromosomally located virulence-associated genes 
such as iron acquisition genes, for example the chromosomal sitD variant, chuA, 
fyuA, and irp2, were frequently found in APEC and also among UPEC and NMEC 
(Ewers et al., 2007). These results demonstrated that very closely related clones can 
be recovered from extraintestinal infections in humans and poultry. 
Currently recognized putative VFs of ExPEC include adhesins, siderophores, toxins, 
protectins, and invasins, has and have been demonstrated within pathogenicity-
associated islands (PAIs) and on plasmids. Ewers et al. suggested that ColV 
plasmids, commonly found in APEC, and might be the source of the plasmid in 
human UPEC and NMEC strains, were associated with virulence genes tsh, iss, and 
the episomal sit locus. (Ewers et al., 2007). Rodriguez-Siek et al. suggested that a 
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typical member of the APEC pathotype is likely to contain several iron transporter-
encoding genes, like irp2, fyuA, iutA, iroN, and sitA, and plasmid-associated genes, 
including cvi/cvaC, tsh, and iss (Rodriguez-Siek et al., 2005b). Several PAIs and 
genetic islands harbouring ireA and pap operon genes have been identified in APEC 
including PAI I (APEC-O1) (Kariyawasam et al.,  2006).  PAI I (APEC-1)-related 
genes were observed in strains belonging to the APEC pathotype and also in UPEC 
and NMEC (Ewers et al., 2007). 
4.2. Association of phylogenetic groups and virulence factors 
Phylogenetics is the study of genetic distance among groups of organism. Phylogenic 
relationships have been traditionally studied based on morphological data. An initial 
phylogeny, obtained through cluster analysis of multilocus enzyme electrophoresis 
(MLEE) data for 35 enzyme-encoding loci of the standard reference collection of 72 
E. coli strains (ECOR), defined six major phylogenetic groups, designated A, B1, 
B2, C, D and E (Tenaillon et al., 2010, Lindstedt et al., 2007). This phylogeny was 
reconstructed within 4 phylogenetic groups A, B1, B2, and D with a subsequent 
analysis of the ECOR strains based on polymorphisms of 38 loci (Tenaillon et al., 
2010; Herzer et al., 1990).  
Among human E. coli isolates, the phylogenetic B2 group and, to a lesser extent, 
the phylogenetic D group strains have been shown to exhibit numerous 
extraintestinal virulence determinants compared to phylogenetic A and B1 strains 
(Clermont et al., 2000). Among ECOR strains, the most common pattern of 
phylogenetic distribution exhibited by the various VFs, including papG allele III, 
sfa/foc, sfaS, focG, hlyA, cnf1, cdtB, kpsMT-III, rfc, and ibeA, was associated with 
group B2. Other VFs were sufficiently found in other phylogenetic groups, but were 
still significantly associated with phylogenetic group B2 (e.g., “K5,” fyuA, ompT, 
and the PAI marker), or with both groups B2 and D (e.g., papAH, papC, papEF, 
papG,and kpsMTII) or with group D only (e.g., papG allele II, iha, K1, and iutA) 
(Johnson et al., 2001). Johnson et al. reported most of E. coli isolates from 
bacteremic patients (65.7%) belonged to phylogenetic group B2, whereas 11.6%, 
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10.5%, and 12.2% belonged to groups A, B1, and D, respectively. More than half 
(97/181, 53.6%) of the bacteremic-inducing E. coli strains were of urinary or 
pulmonary tract origin; 78/97 (80.4%) of these strains belonged to group B2 
(Johnson et al., 2002a). Picard et al. reported that strains of the B2 phylogenetic 
group were highly virulent, killing in mice, and possessed the greatest number of 
virulence determinants. In contrast, commensal strains belong mainly to phylogenetic 
groups A and B1, were devoid of virulence determinants, and did not kill mice 
(Picard et al., 1999). Moulin et al. reported that most avian and human strains 
belonging to phylogenetic subcluster B2-1 expressed the K1 antigen and presented 
no significant differences concerning the presence of other virulence factors (Moulin-
Schouleur et al., 2007). Johnson et al. reported that group B2 neonatal meningitis 
isolates had a significantly higher prevalence of many VFs than even the group B2 
ECOR strains ( Johnson et al., 2002b). 
However, the phylogenetic distribution of the various ExPEC virulence factors 
varied among ExPEC strains from animals and retail food. Among all ExPEC 
isolates recovered from retail meat, papC was significantly positively associated with 
phylogenetic group B1 and negatively associated with group B2, whereas kpsMTII 
was negatively associated with groups B1 and A and positively associated with group 
B2. Other virulence genes, including afa/dra, sfa/foc, iutA, papA, were widely 
dispersed and were not significantly associated with any phylogenetic group (Xia et 
al., 2011). Phylogroup B2 and D isolates from pigs, pork, broiler poultry and broiler 
poultry meat carried more virulence genes in comparison with phylogroup A and B1 
isolates (Jakobsen et al., 2010). A significant association was observed between the 
presence of sitA and group D and also the presence of tsh and group D in the APEC 
isolates (Wang et al., 2010).  
5. Antimicrobial resistance (AMR) of E. coli  
In recent years, antimicrobial resistance in bacteria of animal origin and the potential 
for transmission of resistant bacteria from animals to humans have become a public 
health concern (de Jong et al.,  2012). E. coli is a candidate vehicle for such transfers 
because of its diversity and also because it constitutes part of the microflora in the 
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gastrointestinal tracts of both humans and animals. It is sensitive to selection pressure 
exerted by antimircrobial use and carries genetic mobile elements to achieve such 
transmission (Hammerum & Heuer, 2009). Thereby, E. coli of animal origin may act 
as a donor of antimicrobial resistance genes for other pathogenic bacteria. Johnson et 
al. concluded that some drug-resistant human fecal E. coli isolates may originate 
from poultry (Johnson et al., 2007a). Acquired antimicrobial resistance is particularly 
problematic when it occurs in ExPEC, the distinctive E. coli strains that possess the 
specialized virulence factors (VFs) required for extraintestinal disease (Johnson & 
Russo, 2002).  
5.1. Mechanisms of antimicrobial resistance 
 
Bacteria may acquire resistance to antimicrobials through several mechanisms. First, 
resistance can be mediated by chromosomally located genes encoding enzymes that 
inactivate the antimicrobial agent before it can have an effect (Tenover, 2006). For 
example, beta-lactamases play a major role in intrinsic and acquired resistance to 
beta-lactams in bacteria, predominantly in Gram-negative bacteria. Chromosomal 
beta-lactamases were found in E. coli that showed significant resistance to 
penicillins, monobactams and cephalosporins (Li et al, 2007)  Second, bacteria may 
acquire efflux pumps that extrude the antibacterial agent from the cell before it can 
reach its target site and exert its effect (Tenover, 2006). For example, the efflux 
pump system AcrAB-TolC confers intrinsic resistance to quinolones in E. coli (Li, 
2005). Third, bacteria may acquire mutations that change the binding site of the 
antimicrobial agents. Mutations on gyrA encoded DNA gyrase and parC encoded 
topoisomerase IV, which are the targets of the quinolone drugs, were associated with 
resistance to quinolones in E. coli isolates (Chen et al, 2001).  
Bacteria also develop resistance through the acquisition of mobile genetic elements 
such as resistance plasmids including those transposon- and integron-associated (Li, 
Tenover). This provides an efficient mechanism for rapid horizontal and vertical 
dissemination of antimicrobial resistance determinants among bacteria. The well-
known plasmid-mediated mechanisms have led to resistance to almost every class of 
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clinically important antimicrobials, such as beta-lactams, aminoglycosides, 
macrolides, quinolones, tetracyclines, chloramphenicols, sulphonamides and 
trimethoprim (Li, 2005, Tenover, 2006, Li et al., 2007, Skold, 2001).  
5.2. Antimicrobial use and emergence of antimicrobial resistance in food 
animals 
5.2.1. Antimicrobial use in animal production 
Antimicrobial agents have been used for the prevention and treatment of bacterial 
infections in animals and are also still used for growth promotion in animal 
husbandry in many countries (Fabrega et al.,  2008). The use of antimicrobial agents, 
however, can cause the emergence and dissemination of antimicrobial resistance 
genes in bacteria (Harada & Asai, 2010).  
Because of the concern for the spread of antimicrobial-resistant bacteria from the 
large reservoirs in food animals, European countries have banned the use of 
antimicrobials as growth promoters by January 2006 (Hammerum & Heuer, 2009). 
To assist the microbiological safety assessment of pre- and post-market evaluation of 
veterinary antimicrobials, Health Canada has categorized antimicrobial agents based 
on the indication and the availability of alternative antimicrobials for the treatment of 
infections in human medicine. According to this categorization, antimicrobials are 
classified into 4 categories as i) very high importance, ii) high importance, iii) 
medium importance and iv) low importance in human medicine (http://www.hc-
sc.gc.ca/dhp-mps/vet/antimicrob/amr_ram_hum-med-rev-eng.php).  
For E. coli, first- and second-generation cephalosporins and sulfonamides are listed 
as highly important antimicrobial agents for the treatment of E. coli infection in 
humans (Hammerum & Heuer, 2009). Several cephalosporins are widely used in 
veterinary clinical therapy. Sulfonamides are commonly used for the treatment of un-
complicated urinary tract infection in humans. Sulfonamides, in combination with 
trimethroprim, are also commonly used for treatment of diarrhea in weaner pigs. 
Fluoroquinolones are broad-spectrum antimicrobial agents that are highly effective 
for the treatment of a variety of infections in humans and animals. Legal restrictions 
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aimed at reducing the use of fluoroquinolones in food animals have been introduced 
in certain countries such as the United States and Denmark. In 2005, The US Food 
and Drug Administration withdrew the fluoroquinolones sarafloxacin and 
enrofloxacin, which were used to treat E. coli infections in poultry ( 
www.gpo.gov/fdsys/pkg/FR-2005-08-01/html/05-15224.htm). In Canada, 
antimicrobial use via feed was the most common route of exposure. The most 
common classes of antimicrobials administered via feed were 
macrolides/lincosamides and tetracyclines (Deckert et al., 2010). Fluoroquinolones 
are not licensed for use in pigs or chickens, but since October 2012, injectable 
enrofloxacin is licensed in Canada for treating swine respiratory disease 
(http://www.swinehealth.ca/newsarchives.php). 
In Vietnam, few data are available on antimicrobial use as veterinary drugs and feed 
additives, but it is known to be widespread. Antimicrobials are the most common 
registered drugs, accounting for 70% of all drugs included in the list of veterinary 
drugs approved for circulation 
(http://www.cddep.org/sites/cddep.org/files/publication_files/VN_Report_web_1.pdf
?issuusl=ignore). Currently, there are eleven groups of antimicrobials used in 
animals, including: β-lactams, aminoglycosides, macrolides, tetracycline, quinolones 
and fluorquinolones, phenicols, polymyxins (colistin), pleuromutilins, lincosamides, 
sulfamides and trimethoprim. Results of a survey on antimicrobial use in pig farms in 
South Vietnam showed that amoxicillin, gentamicin, enrofloxacin, norfloxacine, 
tetracycline, ampicillin, and florfenicol are the most commonly used antimicrobials.  
5.2.2.The trend in antimicrobial resistance in E. coli isolates from food-
producing animals 
The prevalence of antimicrobial resistance in E. coli isolated from food-producing 
animals has been monitored in several countries. The prevalence of resistance in E. 
coli to ampicillin, sulfisoxazole and tetracycline was reported similarly by Canadian 
Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Retail Meat 
Program (http://www.phac-aspc.gc.ca/cipars-picra/2008/) and National 
Antimicrobial Resistance Monitoring System (NARMS) in the United States 
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(http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/Natio
nalAntimicrobialResistanceMonitoringSystem/ucm293578.htm). Resistance in E. 
coli isolates to ampicillin, streptomycin, chloramphenicol and tetracycline was 
reported at higher rates in CIPARS Farm results in compared with than the results 
from European surveillance systems (Deckert et al., 2010). Resistance to 
fluoroquinolones which are regarded as critically important antimicrobials in human 
and animal medicine has been broadly observed in animals and meat, thus, the trends 
of their resistance would need continuous and careful observation (Hammerum & 
Heuer, 2009).  
Although the use of chloramphenicol in food-producing animals has been banned 
since the 1990s, current monitoring data showed that chloramphenicol resistance is 
still prevalent in E.coli isolates from animals in China and Japan (Harada & Asai, 
2010;  Wang et al., 2010). The use of thiamphenicol and florfenicol, which belong to 
the same family as chloramphenicol, may be one of the factors causing the 
persistence of chloramphenicol resistance in food-producing animals.  
In Vietnam, a high prevalence of antimicrobial resistance in E. coli isolates from 
poultry, poultry meat, beef and pork was reported in 2008 (Van et al.,  2008). The 
rates of multi-resistance in E. coli isolates which showed resistance to three or more 
different classes of antimicrobials were up to 89.5% in poultry meat, 95% in poultry 
faeces and 75% in pork isolates. Resistance in E. coli was most frequently observed 
to tetracycline, sulfafurazole, ampicillin, amoxicillin, trimethoprim, chloramphenicol, 
streptomycin, nalidixic acid and gentamicin. Additionally, E. coli isolates also 
displayed resistance to fluoroquinolones, with poultry isolates showing the highest 
rates of resistance.  
5.3. Resistance of E. coli to category I antimicrobials 
5.3.1. Resistance to fluoroquinolone 
Quinolones and fluoroquinolones are groups of antimicrobial compounds that are 
commonly used for the treatment of many bacterial infections. However, resistance 
to fluoroquinolones has increased globally, particularly in members of the 
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Enterobacteriaceae (Li, 2005). Quinolones target the DNA gyrase and 
topoisomerase IV enzymes of the bacteria, thus preventing DNA replication (Higgins 
et al., 2003). The main resistance mechanisms to quinolones are mutations in the 
gyrA and parC genes that alter the conformation of target amino acid residues within 
the protein (Jacoby, 2005).  
Plasmids can also directly produce resistance to quinolones due to the presence of 
plasmid-mediated quinolone resistance (PMQR) genes (Jacoby, 2005). The first 
PMQR gene to be described was named qnrA and encodes a 218 aa pentapeptide 
repeat protein that is capable of protecting the DNA gyrase from the activity of 
quinolones (Robicsek et al., 2006a). Since the discovery of qnrA, two related PMQR 
proteins have been described; these proteins are thought to act in a manner 
comparable to qnrA, as they share 40 and 59 % amino acid similarity and have been 
named qnrB and qnrS, respectively (Jacoby et al., 2006). The qnr determinants were 
identified in ciprofloxacin-resistant E. coli strains isolated from clinical cases in 
China (Wang et al., 2003). A high prevalence of qnr determinants was also 
identified, particularly the qnrS gene, in both E. coli community- and hospital-
associated strains in Vietnam (Le et al., 2009).  
An additional PMQR determinant has also been described, which has resistance 
mechanisms distinct from that of the qnr genes. The aac(6’)-Ib-cr gene, which 
encodes a variant aminoglycoside acetyltransferase capable of modifying 
ciprofloxacin and reducing its activity, have been emerged more recently, but might 
be even more prevalent than the qnr genes (Robicsek et al., 2006b). The aac(6’)-Ib-
cr gene was detected in E. coli and K. pneumoniae from both hospital and 
community strains in Vietnam, albeit at a comparatively higher frequency in clinical 
strains (Le et al., 2009).  
5.3.2. Resistance to cephalosporins 
Extended-spectrum β-lactamases (ESBLs) are bacterial enzymes that degrade 
oxyimino-cephalosporins such as cefotaxime and ceftazidime (Paterson & Bonomo, 
2005). Genes encoding extended-spectrum β -lactamases (ESBL) are often located 
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on conjugative plasmids (Pitout & Laupland, 2008). These most common plasmid-
mediated ESBLs include the TEM-, SHV- or CTX-M-type. The CTX-M enzymes, 
named due to the potent hydrolytic activity of these β -lactamases against 
cefotaxime, have become the most prevalent family of ESBLs among 
Enterobacteriaceae (Hammerum & Heuer, 2009). To date, more than 80 CTX-M 
enzymes have been isolated (Paterson & Bonomo, 2005). Of the different CTX-M–
type ESBLs, CTX-M-15 was the most common ESBL associated with human 
ExPEC strains isolated from UTI (Coque et al., 2008).  
Many studies have demonstrated the presence of the genes encoding ESBLs in E. 
coli isolates from animals and meat. The genes blaTEM-1, blaCTX-M-14, blaCTX-M-1, blaCTX-
M-2  were found in ESBLs-producing E. coli isolates from swine and poultry (Tang et 
al., 2011, Giufre et al., 2012). blaTEM-52 and blaCMY-2 were found in E. coli recoverd 
from retail meats (Jensen et al., 2006, Yan et al., 2004). 
5.4. Resistance of E. coli to category II antimicrobials 
5.4.1. Resistance to penicillins 
A variety of beta-lactamases have been identified in bacteria derived from food-
producing and companion animals. Beta-lactamase are classified on the basis of their 
primary structure into four molecular classes A through D (Jacoby & Munoz-Price, 
2005). Gram-negative bacteria usually produce chromosomal AmpC-type beta-
lactamases belonging to the Ambler class C (Li et al., 2007) . Other plasmid-encoded 
b-lactamases in Escherichia coli and other Enterobacteriaceae were identified such 
as TEM-1 or SHV-1 belonging to class A enzymes (Jacoby and Munoz-Price, 2005).  
BlaTEM was found frequently in E. coli derived from pigs and poultry in Vietnam and 
China (Van et al,. 2007, Tang et al., 2011). Substitution of amino acid sequences at 
TEM-1 or SHV-1 resulted in TEM or SHV-type ESBLs (Li et al., 2007). 
5.4.2. Resistance to trimethoprim/sulfamethoxazole  
Sulfonamide and trimethoprim have been used for treatment of E. coli infections in 
humans, and the presence of sulfonamide and trimethoprim resistance can lead to 
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treatment failure in urinary tract infection. Plasmid-mediated resistance to 
sulfonamide and trimethoprim is caused by drug-resistant variants of the 
chromosomal target enzymes dihydropteroate synthase and dihydrofolate reductase, 
respectively (Skold, 2001). Three genes, sul1, sul2 and sul3, coding for sulfonamide-
resistant dihydropteroate synthases have been identified (Hammerum & Heuer, 
2009). 
The combination of trimethoprim with sulfonamides increases its effectiveness 
against a broad spectrum of bacteria including E. coli and other Enterobacteriaceae. 
However, the resistance rates of E. coli to TMP-SMX have increased recently. In 
several regions of the United States, the resistance rate of UPEC strains to TMP-
SMX was reported over 20% to 50% (Solberg et al., 2006). The highest rate of 
resistance of E. coli to TMP-SMX occurs most frequently in urinary tract infections 
in women. The class 1 integron which contains sulI gene was found in about 70% 
strains of E. coli resistant to TMP-SMX (Solberg et al., 2006, Fluit & Schmitz, 
2004).  
5.5. Resistance to category III antimicrobials 
5.5.1. Resistance to tetracyclines 
Tetracycline is one of the most widely used antimicrobials in animal production 
worldwide. The beneficial effect on growth rate and feed utilization of tetracyclines 
were first discovered in poultry, then observed in swine and cattle, leading to the 
development of both chlortetracycline and oxytetracycline as animal growth 
promoters (Chopra & Roberts, 2001). Resistance to tetracyclines has emerged in 
many commensal and pathogenic bacteria due to genetic acquisition of tet genes. 
Since tet genes can be located in integrons, the use of tetracyclines as growth 
promoters could result in selection and transfer of resistance to unrelated 
antimicrobials to humans in bacterial isolates whose resistance gene cassettes are 
also incorporated within the integron.  A high prevalence of tetracycline-resistant E. 
coli was reported in most food producing animal species (Maynard et al., 2003; 
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Boerlin et al., 2005; Gyles, 2008). The prevalence of strains resistant to tetracycline 
among APEC sometimes exceeded 80% in certain studies (Gyles, 2008).  
5.5.2. Resistance to streptomycin 
The prevalence of streptomycin resistance in strains of E. coli were usually reported 
at high rates regardless of the animal species (Maynard et al., 2003, Boerlin et al., 
2005, Gyles, 2008). The prevalence of streptomycin resistant strains was reported 
exceeding 60% for E. coli from pork and poultry strains in Vietnam (Van et al, 
2008). Among streptomycin-resistant  E. coli, the presence of the strA-strB gene pair 
and the aadA gene have been reported frequently (Sunde & Norström, 2005). The 
aadA gene cassettes, which are located within multiresistance integrons, are among 
the most prevalent gene cassettes in class 1 and class 2 integrons. These genes also 
encode for resistance to spectinomycin which is used therapeutically for bacterial 
respiratory and enteric infections in cattle, pigs and poultry 
(http://www.inchem.org/documents/jecfa/jecmono/v33je06.htm.)  
6. Multi-antimicrobial resistance among E. coli  
6.1. Multidrug resistance associated with ESBLs  
The CMY- or CTX-M-encoding plasmids often contain other multiple resistance 
determinants and are also associated with transposons/integrons (Pitout & Laupland, 
2008). The blaCTX-M-15 gene, often associated with the blaTEM-1, blaOXA-1, and aac(6)-
Ib-cr resistance genes, has been located mainly on plasmids belonging to the 
incompatibility group IncF, plasmids producing type F fimbriae susceptible to phage 
Ff (Carattoli, 2009).  Multiresistance plasmids pEK499 and pEK516 belonged to 
IncFII plasmids harboring blaCTX-M-15 and other resistance genes catB4, tet(A) were 
identified with a major role in the spread of CTX-M-15 ESBLs in E. coli (Woodford 
et al., 2009). 
Considering the similar genetic organization of multidrug resistance determinant-
integron/transposon elements, it is important to note the linkage of ESBL and 
fluoroquinolone resistance in Gram-negative bacteria. PMQR gene qnrA has been 
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found with a gene for β-lactamases CTX-M-9, CTX-M-14, whereas qnrB has been 
located on plasmids carrying genes for CTX-M-15, SHV-12, or SHV-30 (Robicsek 
et al.,  2006). A survey in Canada also showed that E. coli strains producing CTX-M 
enzymes were substantially more resistant to ciprofloxacin than strains lacking 
blaCTX-M genes (Pitout et al., 2007). 
6.2. Multi-resistance associated with PMQR 
PMQR is associated with ESBLs on the same plasmid, and the spread of such 
multidrug resistance plasmids among Enterobacteriaceae strains has a potential 
impact on treating human infections (Nordmann & Poirel, 2005). The linkage of 
qnrB4 and qnrB6 genes with gene encoding for β-lactamases DHA-1, SHV-12 was 
found on IncF plasmids in E. coli and K. pneumoniae (Tamang et al., 2008). In the 
case of qnrS, the gene was co-located in K. pneumoniae possessed blaSHV-12 but not in 
the same plasmid (Lavilla et al., 2008) and also found in E. coli possessed blaTEM-1 
(Ahmed et al., 2007). On the other hand, a number of studies described qnr genes in 
association with non-β-lactamase resistance genes, such as aac(6′)-Ib-cr, aadA1, 
aadA2, dfrA1, dfrA12, and catB2 (Rodríguez-Martínez et al., 2011). 
7. Association between virulence and antimicrobial resistance of 
ExPEC 
The genetic association between virulence genes and antimicrobial resistance and 
dissemination may be provided by the coexistence of different mobile genetic 
elements such as plasmids, integrons, transposons (Johnson, 1991; Johnson et al., 
2004). A multiresistant E. coli K52 H1 strain carrying a plasmid similar to the Flme 
plasmids was found in an extensive outbreak of severe infections, including 
urosepsis, meningitis, and pneumonia (Phillips et al., 1988). Several of the genes 
encoding putative virulence factors, including tsh, a class 1 integron gene intI1, 
genes encoding aerobactin and CoIV-encoding operons, are found in a conjugative R 
plasmid isolated from an APEC isolate (Johnson et al., 2002c). Sequence analysis of 
a 30-kilobase (kb) region of this plasmid pTJ100 revealed the virulence genes, iucC 
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and traT, tetracycline resistance genes tetA and tetR, β-lactamase gene bla, and also 
two transposons, Tn21 and Tn3. The Tn21-like region included a gene of class 1 
integrons, intI1, and several genes encoding antimicrobial resistance (aadB, catB3, 
qacED1,and sulI) ( Johnson et al., 2004). 
However, the association between virulence genes and antimicrobial resistance 
among ExPEC strains are not well understood, particularly in relation with other 
factors, such as distribution of phylogenetic groups. In a study on UTI isolates, Piatti 
et al (2008) reported phylogenetic group B2 accounted for a significantly higher 
prevalence among fluoroquinolone-susceptible strains than among resistant strain, 
whereas fluoroquinolone-resistant strains harbor fewer virulence factors than 
susceptible strains (Piatti et al., 2008). The lower prevalence of virulence genes was 
also observed among ciprofloxacin-resistant E. coli strains of both human and avian 
origin in comparison with susceptible strains, however no significant difference was 
observed between ciprofloxacin-resistant and susceptible strains in term of 
phylogenetic pattern (Graziani et al., 2009).  
 8. Food animals as a reservoir of extraintestinal pathogenic E. coli 
in humans 
Much current research is investigating the contribution to human infections of food 
animal-associated ExPEC, particularly those strains that are resistant to 
therapeutically important antimicrobial agents. Based on existing evidence, the 
chicken is the food animal source most closely linked to human ExPEC. Poultry meat 
exhibits the highest overall levels of E. coli contamination, and these E. coli are often 
more frequently antimicrobial resistant than E. coli recovered from other meats. 
Poultry-associated E. coli also often possess virulence genes similar to those of 
human ExPEC, suggesting the potential to cause human disease. (Manges & 
Johnson, 2012). Contamination of pork with ExPEC has also been reported; 
however, fewer studies have been conducted to date (Jakobsen et al., 2010).  
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8.1. ExPEC in poultry 
E. coli is considered as a member of the normal microflora of the poultry intestine, 
but certain strains which cause colibacillosis, an acute disease due to respiratory tract 
infectionare designated as avian pathogenic E. coli (APEC). APEC strains are a 
subset of extraintestinal pathogenic E. coli (ExPEC). It is becoming more and more 
apparent that the common presence of a set of virulence-associated genes among 
ExPEC strains as well as similar disease patterns and phylogenetic background 
indicate a significant zoonotic risk of avian-derived E. coli isolates (Ewers et al., 
2007). 
Many of the virulence genes detected in APEC strains such as iroD, tktA 
(transketolase), fruA (fructokinase) are also present in human ExPEC strains that 
cause human neonatal meningitis and UTIs, as well as in animal disease-causing 
ExPEC strains (Schouler et al., 2004). The distribution of some virulence factors was 
independent of the host, whether they originated from human or avian species, for 
example, the adhesion P-fimbriae were found in both O2 strains from UTI, NBM and 
neonatal sepsis, and avian septicemic O2 (Mokady et al, 2005; Ron, 2006). 
Rodriguez-Siek et al. reported two groups of 524 APEC and 200 UPEC isolates 
showed substantial overlap in terms of their serogroups, phylogenetic groups and 
virulence genotypes, including their possession of certain genes associated with large 
transmissible plasmids of APEC (Rodriguez-Siek et al., 2005a). The genome 
sequence of APEC O1:K1:H7 was found to be remarkably similar to that of three 
human UPEC strains, except only 4.5% of genome not found. Also, multilocus 
sequence typing showed that some of the sequenced human ExPEC strains were 
more like APEC O1 than were other human ExPEC strains (Johnson et al., 2007b). 
Ewers et al. found that an APEC O2:K1:H5 strain and an Ont:NM fecal strain 
belonged to sequence type complexes STC95 and STC69, respectively, which 
account for the majority of ExPEC pathotypes from humans, exclusively UTI strains 
(Ewers et al., 2009). These strong similarities of virulence gene profiles between 
ExPEC isolates from poultry meat, broiler poultry and UTI patient, community-
dwelling human isolates were also identified by cluster analysis (Jakobsen et al., 
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2010). Thus, these studies provide evidence that the potential APEC strains might act 
as human UPEC or as a reservoir of virulence genes for UPEC. These strains pose a 
zoonotic risk because either they could be transferred directly from birds to humans 
or they could serve as a genetic donor of ExPEC virulence genes and also potential 
reservoir of antimicrobial resistance genes for other bacteria. 
APEC strains are often resistant to antimicrobials approved for use in poultry, 
including cephradine, tetracyclines, chloramphenicol, sulfonamides, amino-
glycosides and β-lactam antimicrobials (Lutful Kabir, 2010). Recent studies suggest 
that avian E. coli commonly possess plasmid-mediated multidrug resistance (MDR), 
and might serve as reservoirs of MDR for human ExPEC (Johnson et al., 2007a; 
Manges et al., 2007; Jakobsen et al., 2010). However, it was found that APEC 
isolates had a higher frequency of MDR than human ExPEC isolates. Additionally, 
statistical analysis of data on antimicrobial susceptibility, phylogenetic group, and 
virulence gene content showed that ExPEC avian and human isolates segregated 
significantly according to host species and clinical status. Therefore, the actual 
frequency of such transmission relative to the entire human and avian ExPEC 
populations might be relatively low (Johnson et al., 2012).  
Resistance to fluoroquinolones was reported within several years of the approval of 
this class of drugs for use in poultry. Several studies have suggested that 
fluoroquinolone-resistant strains of E. coli that infect humans probably emerged as a 
consequence of using fluoroquinolones in poultry. Two major ST clonal complexes 
CC10 and CC23 were found to be associated with ciprofloxacin resistance and multi-
resistance were shared by human and avian isolates (Giufre et al., 2012)  However, 
the hypothesis of an avian origin for the fluoroquinolone-resistant human ExPEC 
strains has yet to be determined. Based on analysis of phylogenetic backgrounds and 
virulence gene profiles, Graziani et al. concluded that ciprofloxacin-resistant strains 
in humans were clearly distinct from ciprofloxacin-resistant avian strains (Graziani et 
al., 2009).  
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8.2.ExPEC in pigs 
Pigs, and consequently, pork may be a source of strains with these ExPEC related 
virulence genes in community-dwelling humans and UTI patients. Jakobsen et al. 
investigated similarities between 145 ExPEC isolates from healthy pigs with 102 
human UTI isolates. Seven virulence genes were found commonly among UTI 
isolates and community-dwelling humans and ExPEC pig isolates (kpsMII, iutA, 
papA, papC, hlyD, sfaS, focG) (Jakobsen et al., 2010). Furthermore, 7% and 11% 
ExPEC isolates from pigs, respectively, belonged to phylogroups B2 and D which 
encompass potent human ExPEC isolates causing UTI, bacteremia and meningitis. 
In comparing ExPEC strains causing human UTI (18 strains) or bacteremia (14 
strains) with 19 strains causing bacteremia in calves and piglets, Girardeau et al. 
showed that these piglet strains shared virulence factors such as iutA and iroN, and 
also carry the same O antigens as  human ExPEC strains (Girardeau et al.,  2003). 
Maynard et al. compared 39 resistant ExPEC strains from animals (15, 8, 8, and 8 
from swine, cattle, poultry, and pets, respectively) with 70 resistant human ExPEC 
strains. Fifty-one percent of the animal isolates and 50% of the human isolates were 
resistant to more than 3 antimicrobial compounds. Most of the animal strains (67%) 
belonged to phylogenetic groups A and B1; in contrast, 77% of the human strains 
belonged to groups B2 and D. Phylogenetic group B2 made up 54% of the human 
ExPEC strains and 88% of the pet strains (Maynard et al., 2004). Of 61 human-
source ExPEC isolates, Johnson et al. demonstrated that all belonged to phylogenetic 
group B2 (66%) or  D (34%). However, 28 ExPEC strains isolated from cattle and 
swine clinical cases belonged mostly to group A (82%) or B2 (11%). Certain ExPEC 
VFs including papA, fyuA, iutA, and ompT were found commonly associated 
(>50%) with ExPEC isolates from humans, swine, and cattle (Johnson et al, 
2003a). 
Recently, the frequency of porcine ExPEC was reported to increase from 
3.1% in 2004 to 14.6% in 2007, suggesting that the prevalence of porcine 
ExPEC in China is increasing (Tan et al., 2012). The O2 and O78 antigens 
implicated in neonatal meningitis and UTI caused by ExPEC in humans 
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(Ron, 2006) were found among these porcine ExPEC. In addition, the higher 
frequency of ExPEC VFs, including fimH, fyuA, iutA, iroN, kpsMT II, traT  
and sfa/foc, among the porcine ExPEC isolates was also consistent with the 
previously demonstrated high frequency of these factors in UPEC and NMEC 
in humans (Bingen-Bidois et al., 2002; Johnson et al., 2002b; Sannes et al., 
2004). Together, these findings suggest that porcine strains of E. coli may be 
potentially zoonotic to humans.  
8.3 Prevalence of ExPEC in food derived from animals 
Evidence showing that food can be a reservoir for extraintestinal E. coli includes 1) 
community-based outbreaks of extraintestinal infections caused by epidemic strains 
of E. coli causing UTIs (Manges et al., 2001) and other severe infections (Manges et 
al.,  2004); 2) the determination that these epidemic strains share antimicrobial drug 
susceptibility patterns and genotypes with isolates from retail meat (Johnsonet al., 
2005b); and 3) the epidemiologic association between retail meat consumption and 
intestinal acquisition of antimicrobial drug–resistant E. coli causing UTIs (Manges 
et al., 2007). 
Vincent et al. compared antimicrobial susceptibility, O:H serotype and genotypes of 
ExPEC isolates from human UTI (n = 353); retail meat (n = 417); and 
restaurant/ready-to-eat foods (n = 74) in different geographic areas in Canada from 
2005 to 2007. Two E. coli clonal groups from retail poultry O25:H4-ST131 and 
O114:H4-ST117 were found to be indistinguishable from E. coli from human UTIs. 
This study provides strong support for the role of food reservoirs or foodborne 
transmission in the dissemination of E. coli causing common community-acquired 
UTIs (Vincent et al., 2010).  
In a study of 169 raw cut-up poultry samples obtained from retail grocery stores in 
the Minneapolis–St. Paul area, USA during 2000s, Johnson et al. isolated E. coli 
from 150 (88.8%) samples. Nalidixic acid-resistant E. coli was recovered from 62 
(41%), and nalidixic acid-susceptible E. coli was recovered from 143 (95%), of the 
150 E. coli-positive samples. Of a total of 110 strains that were analyzed for ExPEC 
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VFs, 23 strains were identified as ExPEC. Most of the ExPEC strains (73.9%) 
derived from phylogenetic groups B2 or D. O antigens O7 and O78, related to UTI in 
humans, were determined as the major O types among ExPEC isolates. These 
findings indicated that nalidixic acid–resistant E. coli and ExPEC are common in 
retail poultry meat ( Johnson et al., 2003b). 
A survey of 346 food products (222 vegetable, 74 fruit, and 50 raw meat items) 
purchased in Minneapolis–St. Paul retail establishments in 1999–2000 revealed that 
ExPEC was only isolated from turkey meat (28/50 meat samples) (Johnson, et al,, 
2005a). Of 12 ExPEC strains isolated from the turkey meat, 8 strains derived from 
either phylogenetic group B2 (5 strains) or D (3 strains). 85.7% turkey samples 
contained E. coli strains that were resistant to at least one of 10 antimicrobials tested. 
This survey showed that retail turkey meat is a source of antimicrobial-resistant E. 
coli and ExPEC.  
Johnson et al. also surveyed 1648 retail food items collected in the Minneapolis–
St.Paul area during 2001–2003 for the presence of E. coli, including antimicrobial 
resistant E. coli, ExPEC, and urinary tract infection (UTI)-causing E. coli (Johnson et 
al., 2005b). Most (180/195) of the raw poultry samples were contaminated with E. 
coli. Only 25.6% of the miscellaneous food product samples contained antimicrobial 
resistant E. coli; however, resistant strains were present in most of the raw meat 
products. Approximately 17% of the resistant E. coli strains in beef and pork were 
resistant to 5 antimicrobials, whereas approximately 55% of the poultry samples 
contained strains resistant to 5 antimicrobials. The investigators suggest that the 
presence of resistant E. coli in these food items developed in the farm environment. 
The presence of ExPEC strains was particularly high in poultry products, whereas O-
UTI (UTI associated with specific E. coli O antigens) E. coli strains were more 
evenly distributed. Seventeen of the food-derived ExPEC strains, from phylogenetic 
groups B2 and D, exhibited virulence traits consistent with potential causation of 
human disease (Johnson et al., 2005b). Together, the studies by Johnson et al. 
indicate that meats, particularly poultry, can be an important source of resistant 
ExPEC strains. 
 37 
 
9. Molecular methods for determination of pathogenic E. coli 
Typing methods for discriminating pathogenic E. coli that examine the relatedness of 
isolates at a molecular level have been successfully applied for many years. Several 
methods based on this approach are currently popular, including: polymerase chain 
reaction (PCR), pulsed-field gel electrophoresis (PFGE) and multilocus sequence 
typing (MLST). 
9.1. General information on PCR  
PCR is a revolutionary method for identification of bacterial pathogens (Bartlett 
&Stirling, 2003). PCR is based on using the ability of DNA polymerase to synthesize 
new strand of DNA complementary to the targeted template strand. PCR has been 
used for detection of virulence genes because because it is specific and sensitive 
(Johnson & Russo, 2005).  
The tremendous sensitivity of PCR allows target genes to be detected when present 
in extremely low concentrations, thereby permitting the detection of a minor bacterial 
subpopulation within a complex mixed flora without the need for isolation of the 
organisms of interest (Johnson, 2000). However, for screening the presence of 
virulent markers, the use of PCR is limited by cost and sometimes the availability of 
adequate test sample volume. To overcome these shortcomings, multiplex PCR, a 
modification of the test in which more than one target sequence is amplified using 
more than one pair of primers, has been developed. By targeting multiple genes at 
once, multiplex-PCR is applied successfully for identification of pathogenic E. coli. 
9.2. Multiplex PCR for identification of E. coli pathotype  
9.2.1. Multiplex PCR for identification of intestinal pathogenic E. coli 
Multiplex PCR for identification of E. coli pathogens has been developed since the 
1990s. China et al. developed a multiplex PCR which detects genes including eaeA 
gene encoding intimin and slt genes encoding the Shiga-like toxins. The pairs of 
primers used in the multiplex PCR were chosen on the basis of two criteria: first, 
their amplification products had different sizes, and second, their optimal annealing 
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temperatures were closed. In parallel, the pathotypes of these E. coli strains were 
determined by colony hybridization with slt specific probes. The multiplex PCR was 
proved to be fast and specific and in perfect correlation with the hybridization 
method (China et al., 1996). A multiplex PCR for identification of ETEC and STEC 
was developed by amplifying genes encoding K99 and F41 fimbriae, intimin, and 
Stx1 and Stx2. (Franck et al., 1998). Other multiplex PCR assay was developed, 
enabling simultaneous detection of STEC O103, O91, O113, O145, O111, O157, and 
O26 in beef carcass swabs, beef trim, and ground beef (Valadez et al., 2011). 
9.2.2. Multiplex PCR for identification of ExPEC 
The basis for the establishment of a multiplex PCR for identification of ExPEC were 
incidence and distribution of virulence-associated genes in ExPEC isolates. A 
multiplex PCR protocol for identification of ExPEC has been developed in the 
Reference laboratory for E. coli (EcL) based on detection of tsh, papC, iucD and cnf 
genes simultaneously (http://www.ecl-lab.ca). Another multiplex PCR has been 
applied for identification of ExPEC by screening of 5 virulence markers, including 
papA and papC, sfa/foc afa/dra (Dr binding adhesions), iutA, and kpsM II (group 2 
capsules). In this method, the criterion of “presence of 2 of the five markers,” was 
used to differentiate ExPEC and non-ExPEC isolates (Johnson et al., 2003a).  
9.3. Multiplex PCR for determination of the E. coli phylogenetic group 
Phylogenetic characterization of E. coli strains on the basis of a very few phenotypic 
or genotypic features initially appeared to be very difficult. In the past, phylogenetic 
grouping can be done by multilocus enzyme electrophoresis or ribotyping but both of 
these reference techniques are complex and time-consuming and also require a 
collection of typed strains. (Tenaillon et al., 2010; Chaudhuri & Henderson, 2012) 
Clermont et al developed a multiplex PCR for determining the phylogenetic groups 
of  E. coli strains based on detection of these specific DNA fragments including: (i) 
chuA, a gene required for heme transport in enterohemorrhagic O157:H7 E. coli; (ii) 
yjaA, a gene initially identified in the recent complete genome sequence of E. coli K-
12; and (iii) an anonymous DNA fragment designated TSPE4.C2 (Clermont et al., 
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2000). According to this method, the chuA gene was present in all strains belonging 
to groups B2 and D and was absent from all strains belonging to groups A and B1. 
This result was used to separate groups B2 and D from groups A and B1. In the same 
way, the yjaA gene allowed perfect discrimination between group B2 and group D. 
Finally, clone TSPE4.C2 was present in all but absent from all group A strains. This 
simple and rapid phylogenetic grouping technique has been applied broadly for 
determination of links between phylogenetic group and virulence.  
9.4. Other techniques for identification of pathogenic E. coli 
Molecular typing techniques such as PFGE and MLST that achieve high levels of 
discrimination of pathogenic E. coli have been applied successfully in investigation 
of outbreaks and epidemiological surveillance (Maiden et al., 1998, Sabat et al., 
2013).  
PFGE is a fingerprinting technique involving digestion of the genomic DNA with a 
restriction endonuclease that recognizes specific sequences in the bacterial genome 
(Sabat et al., 2013) The resulting restriction fragments are then separated on an 
agarose gel by using an alternating voltage gradient system known as pulsed-field gel 
electrophoresis, resolving into a pattern based on molecular size (Herschleb et al., 
2007). PFGE has been considered as the ‘gold standard’ among molecular typing 
methods for a variety of clinically important bacteria (Sabat et al., 2013). The 
network for foodborne bacterial disease surveillance (PulseNet) has developed PFGE 
standard protocols for molecular subtyping of E. coli O157:H7, Salmonella enterica 
serotype Typhimurium, Listeria monocytogenes, and Shigella species (Swaminathan 
et al., 2001).   
MLST has become the method of choice for bacterial typing recently (Sabat et al., 
2013). In MLST, internal sequences (of approximatively 450–500 bp) of several 
housekeeping genes are amplified by PCR and sequenced. For each locus, unique 
sequences (alleles) are assigned arbitrary numbers and, based on the combination of 
identified alleles (i.e. the ‘allelic profile’), the sequence type is determined. By using 
MLST technique, E. coli ST23 was identified as a major type among APEC O78 
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isolates in Japan (Ozawa et al., 2010). The other sequence type E. coli ST131 was 
found broadly disseminated among CTX-M-15 extended-spectrum beta-lactamase-
producing E. coli isolated from human and also detected in animals and foods 
(Rogers et al., 2011). 
10. Rationale and objectives of the study 
Previous studies show the occurrence of STEC, EPEC and ExPEC in pigs and 
poultry on farms and at abattoirs. Several studies show a general trend of increasing 
prevalence of pathogenic and antimicrobial resistant E. coli strains of meat and meat 
products. Furthermore, several studies also show that virulence genes and 
antimicrobial resistance genes are sometimes carried by the same genetic elements, 
which suggests a possible association between these genes. Antimicrobial resistance 
is of increasing concern due to the overuse of antimicrobials in animal husbandry. It 
is therefore necessary to study the presence of these virulence genes and 
antimicrobial resistance among potentially pathogenic E. coli. 
The objectives of this study are as follows: 
- To investigate the occurrence of E. coli strains carrying virulence genes 
associated with STEC, EPEC, and  ExPEC in pigs and poultry on farms and in 
abattoirs in Vietnam,  
- To characterize these potentially pathogenic strains for phylogenetic group, and 
antimicrobial resistance profile. 
- To evaluate the prevalence of AMR genes among potentially pathogenic E. coli 
strains from pigs and poultry on farms and in abattoirs. 
- To determine the associations between the presence of AMR genes and 
virulence genes of E. coli strains from pigs and poultry on farms and in abattoirs.
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Sampling of feces and carcasses.  
Carrying out of PCR on fecal samples and carcass samples for detection of virulence 
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Carrying out of PCR of E.coli isolates for detection of virulence genes and 
antimicrobial resistance genes (article in preparation). 
Carrying out of PCR of ExPEC isolates for determination of phylogenetic groups 
(article in preparation). 
Carrying out of antimicrobial susceptibility testing of ExPEC isolates  
Statistical analysis of results of the prevalence and associations of virulence genes 
and antimicrobial resistance of ExPEC isolates 
Writing the article: Potential pathogenicity and antimicrobial resistance of 
Escherichia coli from pigs and poultry on farm and at the abattoir in Vietnam 
Writing the literature review and discussion of results.  
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ABSTRACT 
Zoonotic potential pathogenic Escherichia coli could arise from poultry and pig 
reservoirs. The aim of this study is  to investigate the occurrence of E. coli strains 
carrying virulence genes associated with STEC (Shiga toxin-producing E. coli), 
EPEC (Enteropathogenic E. coli), and ExPEC (Extraintestinal pathogenic E. coli) in 
pigs and poultry on-farm and at abattoirs in Vietnam. Samples of feces and carcasses 
were collected at selected pig and poultry farms and abattoirs, in which animals were 
traced from farms to the abattoir. A total of 13.1% strains from all sources were 
classified as potential ExPEC, possessing one or more virulence genes (iucD, tsh, 
papC and cnf).  Few isolates of other pathotypes were observed. All ExPEC 
virulence genes, except cnf, were more frequently found in isolates from poultry than 
in isolates from pigs. A higher proportion of ExPEC isolates belonging to 
 44 
 
phylogenetic group D was observed in poultry. Multi-drug resistance was frequently 
observed in ExPEC isolates from both pigs and poultry. Nalidixic acid and 
ciprofloxacin resistance were significantly associated with poultry feces isolates 
(P<0.05). blaTEM gene was more frequently associated with poultry isolates, whereas 
qnr and aac(6’)-Ib genes were present at low prevalence in pig and poultry isolates. 
This study demonstrates that poultry ExPEC isolates are potentially more pathogenic 
than pig ExPEC isolates, and ExPEC isolates in pig and poultry carcasses may 
originate from pig and poultry feces, due to contamination associated to slaughtering 
process. Thus, meats particularly from poultry, might be a vehicle for transmission of 
zoonotic ExPEC strains. 
 
INTRODUCTION 
Escherichia coli is a common micro-organism in the gastrointestinal tract of humans 
and animals. From a genetic and clinical perspective, E. coli strains can be broadly 
categorized as commensal strains, intestinal pathogenic strains, and extraintestinal 
pathogenic E. coli (ExPEC) (Russo & Johnson, 2003). Intestinal pathogenic E. coli 
such as enteropathogenic E. coli (EPEC) and Shiga toxin-producing E. coli (STEC) 
have been well recognized as causes of gastrointestinal disease, mostly consisting of 
more or less severe diarrhea in humans and animals. ExPEC strains do not produce 
enteric disease; however, they cause diverse infections, including urinary tract 
infections (UTIs), meningitis and septicemia, in both humans and animals (Smith et 
al., 2007). ExPEC express a variety of virulence-associated genes instead of having a 
common virulence mechanism (Johnson, 1991; Smith et al., 2007). Typical virulence 
factors of ExPEC include adhesins, siderophores for iron acquisition, capsules, 
toxins, proteases, invasins, and serum resistance proteins (Kaper et al., 2004). Recent 
studies indicate retail meat may be an important vehicle for transmission of ExPEC 
that share characteristics with human clinical strains (Jakobsen et al., 2010; Johnson 
et al., 2005a). In addition, it was suggested that meat consumption was 
epidemiologically associated with infection with antimicrobial-resistant ExPEC that 
causes UTI (Johnson et al., 2005b; Johnson et al., 2003b). These findings suggest the 
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hypothesis that potentially zoonotic ExPEC could arise from poultry and pig 
reservoirs following contamination of the meat in abattoirs or in retail-food.  
There have been no published studies on the prevalence of STEC, EPEC, and ExPEC 
in pigs and poultry on-farm in Vietnam. In addition, few current data are available on 
the prevalence of antimicrobial-resistant E. coli on farms and in abattoirs in this 
country. The aim of this study is to investigate the occurrence of E. coli strains 
carrying virulence genes associated with STEC, EPEC, and  ExPEC in pigs and 
poultry on farms and in abattoirs, and to characterize these potentially pathogenic 
strains for phylogenetic group, and antimicrobial resistance profile. 
 
MATERIALS AND METHODS 
Sample collection 
Fecal samples were taken in 10 pig farms in the provinces of Ninh Binh, Thai Binh, 
Bac Giang, Bac Ninh and Hanoi, and 5 poultry farms located in the provinces of Hoa 
Binh, Thai Nguyen, Bac Giang in the North of Vietnam. Samples of carcasses were 
taken at the associated abattoirs (6 pig abattoirs and 2 poultry abattoirs) located in 
Hanoi, Vietnam, in which animals were tracked from the farms to the abattoir. On 
the farms, fecal swabs were randomly collected from five points on each pen floor 
using steriled cotton swabs (Nam Khoa Biotek Company, Ho Chi Minh city, 
Vietnam), then pooled to constitute samples per farm. At the pig abattoirs, swab 
samples were taken from 5-10 randomly selected carcasses. From each carcass, a 
total area of 3x10cmx10cm was swabbed after the final washing step, then swabs 
from 5 carcasses were pooled to constitute one sample. At poultry abattoirs, chicken 
carcasses were collected according to the Vietnam technical regulation QCVN 01 - 
04: 2009/BNNPTNT (www.tcvn.gov.vn/media/66btnptnt2009.doc). Carcasses were 
collected in sterile plastic bags, put on ice in coolers, and sent to the laboratory for 
rinsing. Overall, there were 58 pooled samples of pig feces, 51 pooled samples of 
poultry feces, 21 pooled samples of pig carcasses, and 18 pooled samples of poultry 
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carcasses. (Details of the farms, abattoirs and samples in Annex 1).  All animals were 
healthy both on farms and at abattoirs.  
Sample processing 
All samples were transported to the laboratory at National Veterinary Institute in 
Hanoi, Vietnam. After enriching in peptone water at 37
0
C, overnight, samples were 
cultured on Mac Conkey agar, and incubated at 37
0
C, overnight. All samples were 
kept at 4
0
C until shipping to the EcL laboratory in Canada. 
Identification of virotypes 
Identification of virulence genes: The prevalence of ExPEC, STEC and EPEC 
virulence genes in samples were identified by multiplex PCR as described below. 
Then, PCR tests were carried out with samples consisting of 5 pooled colonies 
selected from cultures of PCR-positive samples. When the PCR reactions of pooled 
samples were positive, all isolates were examined for the presence of the appropriate 
virulence genes. 
Template preparation: Each sample was inoculated in a tube of 5 ml of LB broth, 
then incubated at 37
0
C overnight before extraction of the DNA. Briefly, 1 ml of each 
overnight enrichment was pelleted by centrifugation, re-suspended in 0.5 ml of 
sterile deionized water and boiled for 10 minutes. The boiled cell suspensions were 
centrifuged and the resulting lysates were used for PCR. 
PCR reactions:  The presence of virulence genes encoding for ExPEC, STEC and 
EPEC was determined by multiplex PCRs. The following genes encoding ExPEC 
virulence factors were tested: papC (P fimbriae assembly), cnf (cytotoxic necrotizing 
factor), tsh (temperature-sensitive hemagglutinin), and iucD (aerobactin). stx1, stx2 
genes were tested for STEC and eae gene was tested for EPEC. Two ExPEC strains, 
ECL 13421 and ECL 17088, and one STEC strain, ECL 6611, were used as positive 
controls. The PCRs were performed in 25 μl reaction mixtures containing 5 μl of 
DNA template, 1.0 μM each oligonucleotide primer, 200 μM concentrations of each 
of the four deoxynucleoside triphosphates (GE Healthcare UK Limited-
Buckinghamshire HP7 9NA UK), 10 mM Tris-HCl, pH 9.0, 50 mM KCl, 2.0 mM 
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MgCl2 (BioTools, B & M Labs, S.A-Madrid-Spain), and 1U of Taq polymerase 
(BioTools, B & M Labs,S.A-Madrid-Spain ). PCR was performed for 30 cycles of 
denaturation at 94°C for 30s, annealing at 55°C or 60°C depending on the primer 
(Table I) for 30s, and extension at 72°C for 45s. PCR products were visualized by 
SYBR Green I staining after agarose gel electrophoresis.  
Biochemical tests:  All positive-ExPEC isolates were confirmed to be E. coli by 
biochemical tests, including Simmons citrate agar, mobility and indole. 
Phylogenetic grouping: ExPEC isolates were subjected to phylogenetic grouping by 
a PCR-based method (Clermont et al., 2000) to detect chuA, yjaA, and DNA 
fragment TspE4.C2, using the primers listed in Table 1. The PCR conditions were 
94°C for 3 min, 30 cycles at 94°C for 5s, 59°C for 10s, and a final 5 min extension at 
72°C. Strain ECL2015 was used as positive control. 
Antimicrobial resistance testing: Antimicrobial resistance was determined using 
the disk diffusion method ECL-PROC-055 based on Kirby-Bauer technique. 
Bacterial isolates grown overnight on blood agar were mixed in tubes containing 10 
mL of sterile water to a turbidity of 0.5 McFarland Standard. The contents of the 
tubes were placed onto Mueller-Hinton agar plates using a sterile swab and the 
following disks were applied using aseptic precautions: amoxicillin + clavulanic acid 
(20 + 10 µg), ceftiofur (30 µg), ceftriaxone (30 µg), ciprofloxacin (5 µg), amikacin 
(30 µg), ampicillin (10 µg), cefoxitin (30 µg), gentamicin (10 µg), kanamycin (30 
µg), nalidixic acid (30 µg), streptomycin (10 µg), tetracycline (30 µg), 
chloramphenicol (30 µg), sulfisoxazole (0.25 mg) and trimethoprim + 
sulfamethoxazole (1.25 + 23.75 µg). The plates were incubated at 37°C for 24 h, and 
the diameters of the zones of complete inhibition were measured. The breakpoints 
used were those recommended by the Clinical and Laboratory Standards Institute 
(CLSI) as described in 2007 for most of the antimicrobials and in 2010 for ceftiofur. 
Detection of antimicrobial resistance genes: the multi-resistant isolates were 
examined by uniplex PCR for antimicrobial resistance genes: including blaSHV, 
blaTEM, blaCTX-M-15, blaOXA (extended-spectrum β-lactamases (ESBLs), qnrA, qnrB, 
qnrS and aac(6)-lb (fluoroquinolone) and aadA1 (streptomycin). The PCRs were 
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performed in 25μl reaction mixtures as described above. PCR was performed for 30 
cycles of denaturation at 94°C for 30s, annealing at 48°C, 53°C, 50°C or 55°C 
depending on the primer for 30s, and extension at 72°C for 45s.  
 
RESULTS 
Prevalence of ExPEC, STEC and EPEC in pig and poultry samples 
ExPEC genes were frequently observed in samples of both pig and poultry feces and 
carcasses, whereas the EPEC gene eae occurred at much lower frequency, and STEC 
gene stx1 was only observed in one sample (Table II). Among ExPEC VGs, iucD 
was more prevalent in feces and carcass samples from poultry than those from pigs. 
The VG tsh was most frequent in samples of pig feces but there was no difference of 
tsh frequency in pig and poultry carcasses. papC was more frequent in carcasses 
samples from pigs than those from poultry.  
 
ExPEC from pigs and poultry differed in their virulence gene profiles  
A total of 2505 isolates from samples positive for one or more of the ExPEC VGs 
were tested the presence of iucD, tsh, papC and cnf by PCR. Overall, 328 isolates 
(13.1%) from all sources were classified as potential ExPEC due to the possession of 
one or more of these VGs.  
As observed at the sample level, iucD was less frequently detected in isolates from 
pigs than those from poultry. In contrast to the situation in samples, both tsh and 
papC were also more frequently detected in isolates from poultry feces and carcasses 
than those from pigs. Interestingly, iucD, tsh and papC were more frequently 
detected in isolates from feces than in isolates from carcasses, both in pigs and 
poultry. 
Distribution of ExPEC isolates according to phylogenetic groups  
In order to gain more insight into the pathogenic potential and relatedness of the 
ExPEC from the different animal species at the farm and abattoir levels, isolates were 
tested for phylogenetic groups by PCR. The distribution of phylogenetic groups 
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among isolates from pig feces and carcasses was similar. More than half (> 60%) of 
the ExPEC-positive isolates from pig feces and carcasses fell into group A, which 
were followed by group B1 and group D (Table III).  Among pig isolates, the 
common profiles A-iucD:tsh and A-iucD:papC were observed both on farms and at 
abattoirs, Overall, the tsh virulence profile was more prevalent in pig isolates than in 
poultry isolates, and was most frequently observed in the isolates of group A. 
In contrast, isolates from poultry feces and carcasses showed a substantial difference 
in phylogenetic distribution as compared to those from pigs. Phylogroup A was less 
prevalent in isolates from poultry, and group B1 was far more prevalent in isolates 
from poultry carcasses than in those from all other sources (Table III). In addition, a 
higher proportion of poultry isolates was assigned to group D. Only two poultry feces 
isolates belonged to group B2. Among all tested virulence genes, iucD, tsh and papC 
were associated more frequently with groups A and B1 whereas cnf was associated 
only with group B1. About half of the group B1 isolates from chicken carcasses 
possessed both the virulence genes iucD and tsh. As observed for pig isolates, 
isolates sharing the same combination of virulence genes and phylotypes were found 
both on farms and at abattoirs. For instance, the profiles B1-iucD:tsh and D-
iucD:papC occurred in both poultry feces and carcass isolates. 
ExPEC isolates from poultry were more frequently antimicrobial resistant and 
multidrug resistant than those from pigs 
A total of 132 ExPEC-positive isolates, representative of the virotypes and 
phylotypes found among isolates from the different sources, were selected for 
antimicrobial susceptibility testing. Multi-drug resistance was far more frequently 
observed in isolates from both feces and carcasses in poultry than in those from pigs 
(Table IV). All poultry feces isolates were resistant to 4 or more antimicrobial 
classes. Most notably, poultry-feces isolates were significantly associated with 
resistance to both CIP and NAL (P<0.05), whereas isolates from feces and carcasses 
in pigs were less associated with CIP and NAL resistance than those in poultry. In 
contrast, frequency of resistance to TET, CHL, FIS, SXT and AMP was very high 
among isolates from all different sources. Frequency of resistance to cephalosporins 
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was very low in isolates from all different sources. However, two isolates from 
poultry carcasses, which were found on Mac Conkey agar containing ceftiofur, were 
resistant to both TIO and CRO. Interestingly, one poultry-feces isolate and one 
poultry-carcass isolate shared the same phylo-virotype D-iucD and the same multi-
resistance pattern for ten antimicrobial agents (data not shown).     
Frequency of AMR genes among ExPEC-positive isolates from different sources 
A total of 77 isolates, including isolates from pig feces (n=25), pig carcasses (n=12), 
poultry feces (n=28) and poultry carcasses (n=12), which showed the highest degree 
of multi-resistance, were examined by uniplex PCR for plasmid-mediated ESBL and 
fluoroquinolone associated AMR genes. Among plasmid-mediated quinolone 
resistance (PMQR) genes, qnrS was the most frequently observed in pig-carcass 
isolates  , qnrB was present only in pig-carcass isolates and qnrA was more frequent 
in poultry isolates (Table V). The aac(6’)-Ib gene was detected only in one pig-feces 
isolate and two poultry-feces isolates. Nevertheless, PQMR genes were only 
observed in a small proportion of the ciprofloxacin-resistant isolates (Table VIa). 
Among ESBL genes, blaTEM was found to be significantly associated with poultry 
isolates (P<0.05) (Table V). In addition, blaTEM were more frequently associated with 
AMP –resistant isolates from poultry feces and carcasses than those from pigs (Table 
6b). Only a low prevalence was observed for the other ESBL genes in isolates of all 
origins (Table V). Interestingly, blaCTX-M-15 was found in two poultry-carcass isolates 
recovered from Mac Conkey agar containing ceftiofur and possessing the virulence 
profiles iucD:tsh:papC. Most ampicillin-resistant ExPEC isolates from poultry 
possessed blaTEM whereas only about half of the pigs ExPEC isolates possessed this 
gene (Table VIb). Most of the streptomycin resistant isolates possessed aadA1. 
 
DISCUSSION 
To our knowledge, this is the first study describing the prevalence of potential 
ExPEC isolated from pigs and poultry at farms and in abattoirs in Vietnam. Our 
study also shows the low prevalence of STEC and EPEC in pigs and poultry, which 
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need to be studied further to determine the potential risks of these food-borne 
pathogens in Vietnam.  
In our study, 13.1% of strains from all sources were classified as potential ExPEC 
due to the possession of one or more virulent genes contributing to bacterial 
virulence and uropathogenesis in humans, including iucD, tsh, papC and cnf. For pig-
feces isolates, low prevalence of iucD and tsh gene occurred in 6% (87/1460), and 
2.5% (36/1460) respectively, whereas the occurrence of these genes varied among 
previous studies.  Schierack et al. reported the occurrence of iucD and tsh was 11.8% 
and 5.9% in E. coli isolated from a small group of piglets (Schierack et al., 2008). 
Cortes et al. noted iucD gene was present in only one isolate (1/29) and tsh occurred 
in 24.1% (7/29) of E. coli isolates from pig farms (Cortes et al., 2010). 
Interestingly, our data showed the presence of cnf in pig isolates, which were not 
detected in healthy pigs in other countries (Cortes et al., 2010; Wu et al., 2007). 
Overall, the prevalence of iucD, tsh and papC were respectively higher in poultry 
isolates than pig isolates. However, the specific prevalence of these virulence genes 
in poultry isolates were lower than reported in previous data (Cortes et al., 2010; 
Ewers et al., 2009). Our findings support the hypothesis that ExPECs are more 
predominant in poultry than in pigs (Jakobsen et al., 2010, Cortes et al., 2010). 
The finding that ExPEC virulent factors were much more common in poultry 
carcasses than in pig carcasses, is consistent with previous studies ( Johnson et al., 
2005b; Xia et al., 2011). A similar prevalence of ExPEC was reported in E. coli 
isolated from poultry meat (Johnson et al., 2003b; Xia et al., 2011). Poultry has long 
been considered a source of E. coli strains with zoonotic potential  (Bélanger et al., 
2011; Fairbrother & Nadeau, 2006), therefore, our observations that ExPEC are 
common in poultry meat support the hypothesis of retail meats as a source of 
zoonotic pathogenic E. coli (Johnson et al., 2005b)  
Analysis of phylogenetic groups and virulence profiles suggest that ExPEC isolates 
from poultry are potentially more pathogenic for humans than those from pigs. The 
prevalence of potential ExPEC strains belonging to phylogroup B2 in poultry in 
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Vietnam was much lower than observed in other studies (Cortes et al., 2010; Ewers 
et al., 2009). However, our data are consistent with previous studies in terms of the 
predominant prevalence of phylogroup D-ExPEC strains in poultry versus the 
prevalence in pigs (Cortes et al, 2010). The occurrence of phylogroup D isolates, 
particularly, the presence of B2 poultry isolates, implicate the emergence of ExPEC 
strains which may be related to human clinical ExPEC isolates. Furthermore, among 
these pig farms and associated abattoirs, we found E. coli strains sharing the phylo-
virotype D-iucD and A-iucD. Among these poultry farms and associated abattoirs, 
we also found E. coli strains sharing the same virotypes including phylo-virotypes D-
iucD and, iucD:tsh. These findings indicate that E. coli in pig carcasses may 
originate from pigs on-farm and E. coli in poultry carcasses may originate from 
poultry on-farm. 
Our results showed that multidrug resistance is widespread among these potential 
ExPEC isolates from pigs and poultry. Overall, E. coli isolates recovered from 
carcasses exhibited less resistance to antimicrobials than E. coli from farms. These 
results were consistent with the high multidrug resistance in E. coli from retail meat 
reported in a previous study, which might be explained by the widespread use of 
antimicrobials, often without prescription, in food-producing animals in Vietnam 
(Van et al., 2008). Fluoroquinolones are critically important for the treatment of 
serious infections in humans, such as diarrhea in children (Nguyen et al, 2005). Our 
findings showed that poultry feces isolates were more significantly associated with 
CIP and NAL resistance than those from pigs (P<0.05). These findings were in broad 
agreement with other studies on high prevalence of resistance to  CIP among E. coli 
of pig and poultry origin reported in other Asia countries such as China and Korea 
(Tang et al., 2011; Yang et al., 2004; Lee et al., 2005). In contrast, resistance to CIP 
in E. coli isolates from poultry was reported as either low or non-existent in United 
States, Canada and some European countries (Gyles, 2008). Moreover, our study 
showed that E. coli isolates from poultry carcasses also displayed high resistance to 
NAL and CIP. The association of CIP and NAL resistance was also reported in 
ExPEC isolated from poultry meat in US (Johnson et al., 2005b). Therefore, 
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fluoroquinolone resistance in E. coli induced by the use of these antimicrobials in 
food animals might be a major public health concern in Vietnam.  
As observed in previous studies (Do et al., 2006; Van et al., 2008; Yang et al., 2004), 
most pig and poultry isolates were resistant to TET, STR, AMP, and SXT. It is 
important to note that the two latter antimicrobials are frequently prescribed for 
treatment of UTIs in humans (Talan et al., 2008). Also, more than 70% isolates from 
all sources were resistant to chloramphenicol. Since, chloramphenicol has been 
banned for use in food animals in Vietnam since 2002 according to the Decision No. 
54/2002/QĐ-BNN (http://law.omard.gov.vn/TraC%E1%BB%A9uVB.aspx), the high 
prevalence of chloramphenicol resistance might be caused by the co-selection 
pressure due to use of other antimicrobials in the phenicol group, such as florfenicol, 
in animal production (Harada & Asai, 2010) or the persistence of chloramphenicol-
resistant gene(s) among E. coli populations (Do et al., 2006). It is noteworthy that 
multi-resistance to AMP, CHL, and SXT was also reported in diarrheagenic E. coli 
strains isolated from children in Vietnam (Nguyen et al, 2005). Taken together, these 
results suggest food animals might be a reservoir, and consequently, meats might be 
a vehicle for transmitting antimicrobial resistant E. coli strains which may cause 
infections in humans. 
In our study, the PCR results revealed that 26.2% quinolone-resistant isolates in pig 
and in poultry possessed a qnr gene. However, 62.5% isolates in pigs and poultry 
which possessed qnr genes were susceptible or intermediate to NAL and CIP. Our 
findings supported previous studies which showed PMQR determinants confer low-
level resistance to quinolones and facilitate selection of higher level quinolone 
resistant bacteria (Jacoby et al., 2006; Tran et al., 2005). The aac(6’)-Ib gene encodes 
a common aminoglycoside acetyltransferase responsible for aminoglycoside 
resistance (Ramirez & Tolmasky, 2010). A variant of the aac(6’)-Ib gene, the 
aac(6’)-Ib-cr has been indicated as the gene encoding for enzyme acetylates 
ciprofloxacin and norfloxacin (Poirelet al, 2012). In our study, aac(6’)-Ib gene was 
detected in one isolate from pig farms and two isolates from poultry feces. The 
presence of aac(6’)-Ib might be caused by the use of quinolone and aminoglycoside 
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at pig and poultry farms, that might gradually have generated selection pressure for 
these resistant strains. Overall, our results indicate that other as yet unknown PMQR 
determinants may be responsible for quinolone resistance in ExPEC isolates from 
pigs and poultry in this study. 
In recent years, the dramatic increase in the incidence and prevalence of ESBLs from 
food animals has become a public health concern (Pitout & Laupland, 2008). The 
blaTEM-1-type beta-lactamase gene is widely distributed in E. coli strains from food of 
animal origin (Li et al., 2007). Our findings showed that blaTEM gene was associated 
significantly with potential ExPEC isolates from poultry feces and abattoirs 
(P<0.05). Interestingly, the detection in poultry carcasses of ExPEC carrying blaCTX-
M-15, encoding the most common ESBL associated with human ExPEC from UTI, 
indicates a possible source of this gene for transmission to humans. Further studies 
will elucidate the prevalence of this gene in pig and poultry isolates. 
This study relied on a limited number of virulence genes and AMR genes, thus, the 
prevalence of potential pathogenic strains and AMR strains may be underestimated. 
Further comprehensive studies with epidemiological and genetic tools are needed to 
elucidate more fully the prevalence of pathogenic and AMR strains in food 
producing animals in Vietnam.  
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TABLES 
Table I. List of primers used in the PCR, single PCR conditions, and control strains 
Virulence factor or 
antimicrobial  
Gene Primer Amplicon 
size (bp) 
Annealing 
TM 
Control 
strain 
Reference 
Aerobactin iucD for 5’ AAGTGTCGATTTTATTGGTGTA 
rev 5’ CCATCCGATGTCAGTTTTCTG 
778 60
0
C  
 
ECL17088 Herrero et 
al., 1988. 
Tsh tsh for 5’ GGTGGTGCACTGGAGTGG 
rev 5’ AGTCCAGCGTGATAGTGG 
640 55
0
C 
  
ECL17088 Dozois et 
al., 2000.  
P (PapC) papC for 5' TGATATCACGCAGTCAGTAGC 
rev 5' CCGGCCATATTCACATAAC 
501 60
0
C  
 
ECL 13421  Daigle et 
al., 1994. 
CNF (multiplex)     cnf for 5’TCGTTATAAAATCAAACAGTG 
rev 5’CTTTACAATATTGACATGCTG 
446 60
0
C  
 
ECL 13421 Toth et al., 
2003. 
Stx1 stx1 for 5’ TTA GAC TTC TCG ACT GCA AAG 
rev 5’ TGT TGT ACG AAA TCC CCT CTG 
531 60
0
C  
 
ECL6611 Woodward 
et al., 1992. 
Stx2 stx2 for 5’ TTA TAT CTG CGC CGG GTC TG 
rev 5’ AGA CGA AGA TGG TCA AAA CG 
327 60
0
C  
 
ECL6611 Woodward 
et al., 1992. 
Eae (intimin) eae for 5’ CAT TAT GGA ACG GCA GAG GT 
rev 5’ ATC TTC TGC GTA CTG CGT TCA 
791 60
0
C  
 
ECL6611 Beaudry et 
al., 1996. 
chuA chuA for 5' GACGAACCAACGGTCAGGAT 
rev 5' TGCCGCCAGTACCAAAGACA 
279 59
0
C ECL2015 Clermont et 
al., 2000 
yjaA.1 yjaA.1 for 5' TGAAGTGTCAGGAGACGCTG 
rev 5'ATGGAGAATGCGTTCCTCAAC 
211 59
0
C ECL2015 Clermont et 
al., 2000 
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 Table I. List of primers used in the PCR, single PCR conditions, and control strains (continued) 
Virulence factor or 
antimicrobial  
Gene Primer Amplicon 
size (bp) 
Annealing 
TM 
Control 
strain 
Reference 
Tsp4C2.1 Tsp4C2.1 for 5’ GAGGTAATGTCGGGGCATTCA 
rev 5'CGCGCCAACAAAGTATTACG 
152 59
0
C ECL2015 Clermont et 
al., 2000 
Ampicillin   
   
blaTEM for 5’ GAGTATTCAACATTTTCGT 
rev 5’ACCAATGCTTAATCAGTGA 
857 55
0
C 
 
ECL3482   Maynard et 
al, 2003 
 
Beta-lactamase blaSHV for 5’TCGCCTGTGTATTATCTCCC 
rev5’CGCAGATAAATCACCACAATG 
768 50
0
C 
 
PMON38 Maynard et 
al, 2003 
 
Beta-lactamase blaOXA-1 for 5’GCAGCGCCAGTGCATCAAC 
rev 5’CCGCATCAAATGCCATAAGTG 
198 50
0
C 
 
ECL12572 Maynard et 
al, 2003 
Beta-lactamase blaCTX-M-15 for 5’GCCGTCTAAGGCGATAAACA 
rev 5’CACACGTGGAATTTAGGGACT 
996 50
0
C 
 
SUR 255 Doi et al 
2009 
Streptomycin aadA1 for 5’ CATCATGAGGGAAGCGGTG 
rev 5’ GACTACCTTGGTGATCTCG 
786 50
0
C 
 
PMON38 Ecl Lab 
contact 
Quinolone qnrA for 5’TCAGCAAGAGGATTTCTCA 
rev 5’GGCAGCACTATTACTCCCA 
627 48
0
C J53pMG252 Yue et al, 
2008 
Quinolone qnrB for 5’GATCGGAAAGCCAGAAAGG 
rev 5’ACGATGCCTGGTAGTTGTCC 
469 53
0
C J53pMG298 Yue et al, 
2008 
Quinolone qnrS for 5’ACGACATTCGTCAACTGCAA 
rev 5’TAAATTGGCACCCTGTAGGC 
417 53
0
C J53pMG306 Yue et al, 
2008 
Fluoroquinolone aac(6’)-Ib for 5’TTGCGATGCTCTATGAGTGGCTA 
rev 5’CTCGAATGCCTGGCGTGTTT 
482 55
0
C J53pMG298 Yue et al, 
2008 
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Table II. Virulence genes (VGs) associated with pathotypes of E. coli from pigs and poultry on farms and at abattoirs 
Source 
Total 
 no. of 
samples 
examined 
(n) 
No. of E. coli samples (%) positive for pathotype VG Total  
no. of  
E. coli 
isolates 
examined 
(n) 
No. of E. coli isolates (%) positive for ExPEC 
VG ExPEC STEC and EPEC 
iucD tsh papC cnf stx1 stx2 eae iucD tsh papC cnf Total 
a
 
Pig feces 58 45 (77.6) 53 (91.4) 17 (29.3) 2 (3.4) 1 (1.7) 0 8 (13.8) 1460 87 (6.0) 36 (2.5) 4 (0.27) 3 (0.21) 104 (7.1) 
Pig 
carcasses 
21 16 (76.2) 16 (76.2) 11 (52.4) 0 (0) 0 0 0 250 30 (12.0) 12 (4.8) 4 (1.6) 0 39 (15.6) 
Poultry 
feces 
51 46 (90.2) 38 (74.5) 21 (36.2) 0 (0) 0 0 4 (7.8) 595 116 (19.5) 30 (5.0) 23 (3.9) 0 141 (23.7) 
Poultry 
carcasses 
18 15 (83.3) 14 (77.8) 7 (3.9) 0 (0) 0 0 6 (33.3) 200 44 (22.0) 15 (7.5) 12 (6.0) 0 44 (22.0) 
Total         2505 277 (11.1) 93 (3.7) 43 (1.7) 3 (0.12) 328 (13.1) 
a
: Potential ExPEC isolates within each group 
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Table III. Distribution according to phylogenetic group and virulence gene profile of ExPEC from pigs and poultry on farms 
and at abattoirs 
Source/ 
Phylogenetic group 
No.of 
isolates  
(n) 
Frequency of virotypes (%) 
iucD tsh papC iucD:tsh iucD:papC tsh:papC 
iucD:tsh: 
papC 
iucD:cnf 
iucd: tsh: 
papC:cnf 
Pig feces  
         
A 67 (64.4) 45 (67.2) 12 (17.9) 1 (1.49) 7 (10.4) 2 (3.0) 0 0 0 0 
B1 33 (31.7) 15 (45.5) 3 (9.1) 0 12 (36.4) 0 0 0 2 (6.1) 1 (3.0) 
D 4 (3.8) 3 (75) 1 (25) 0 0 0 0 0 0 0 
Total 104 63 (60.1) 16 (15.4) 1 (1.0) 19 (18.3) 2 (1.9) 0 0 2 (1.9) 1 (1.0) 
Pig carcasses  
         
A 24 (61.5) 12 (50) 7 (29.2) 0 1 (4.2) 2 (8.3) 0 2 (8.3) 0 0 
B1 12 (30.8) 10 (83.3) 2 (16.7) 0 0 0 0 0 0 0 
D 3 (7.7) 3 (100) 0 0 0 0 0 0 0 0 
Total 39 25 (64.1) 9 (23.1) 0 1 (2.6) 2 (5.1) 0 2 (5.1) 0 0 
Poultry feces  
         
A 69 (48.9) 36 (52.2) 10 (14.5) 8 (11.6) 7 (10.1) 0 6 (8.7) 2 (2.9) 0 0 
B1 43 (30.5) 40 (93.0) 1 (2.3) 0 2 (4.7) 0 0 0 0 0 
B2 2 (1.4) 2 (100) 0 0 0 0 0 0 0 0 
D 27 (19.1) 18 (66.7) 0 0 2 (7.4) 7 (25.9) 0 0 0   0 
Total 141 96 (68.1) 11 (7.8) 8 (5.7) 11(7.8) 7 (5.0) 6 (4.3) 2 (1.4) 0 0 
Poultry carcasses  
         
A 8 (18.2) 8 (100) 0 0 0 0 0 0 0 0 
B1 32 (72.7) ;17 (53.1) 0 0 5 (15.6) 0 0 10 (31.3) 0 0 
D 4 (9.1) 2 (50) 0 0 0 2 (50) 0 0 0 0 
Total 44 27 (61.4) 0 0 5 (11.4) 2 (4.5) 0 10 (22.7) 0 0 
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Table IV. Antimicrobial resistance of potential ExPEC E. coli isolates from pigs and poultry on farms and at abattoirs 
 
a   
Classes of antimicrobial agents: (1) β-Lactam; (2) Fluoroquinolones; (3) Aminoglycosides: (4) Sulfonamide combinations; (5) 
Phenicols; (6) Sulfonamides; (7) Tetracyclines.  
b  
AMP, ampicillin; AMC, amoxicillin/clavulanic acid ; TIO, ceftiofur; FOX, cefoxitin; CRO, ceftriaxone; NAL, nalidixic acid; 
CIP, ciprofloxacin; AMK, amikacin ,GEN, gentamicin; KAN, kanamycin; STR, streptomycin; FIS, sulfisoxazole, CHL,  
chloramphenicol, TET, tetracycline , SXT, trimethoprim-sulphamethoxazole. 
c
 P <0.05 for comparison of indicated group with all other groups. 
 
Source 
 
Total 
no. of 
isolates 
(n) 
No. of isolates by 
no. of AM 
classes in the 
resistance pattern 
% of resistant isolates
 
by antimicrobial class
a
 and antimicrobial
b
 
(1) (2) (3) (4) (5) (6) (7) 
0-1 2-3 4-5 6-7 AMP AMC TIO FOX CRO NAL CIP AMK GEN KAN STR SXT CHL FIS TET 
Pig  feces 40 0 2 14 24 92.5 10 0 0 0 47.5 30 0 45 27.5 80 70 70 92.5 100 
Pig carcasses 24 0 3 7 14 91.7 12.5 0 4.17 0 45.8 25 0 29.2 25 62.5 79.2 79.2 75 100 
Poultry feces 47 0 0 3 44 91.5 23.4 0 0 0 89.4
c 
80.9
c 
2.1 68.1 74.5 83 100 93.6 97.9 100 
Poultry 
carcasses 
21 0 0 3 18 95.2 14.3 9.52 0 9.52 61.9 38.1 0 38.1 57.1 66.7 100 81 100 100 
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Table V. Frequency of antimicrobial resistance genes and association of AMR genes and VGs among 77 
potential ExPEC isolates from pigs and poultry on farms and at abattoirs 
Source/  
Virulence gene 
profile 
Total 
No. of 
isolates 
(n) 
 No. (%) of isolates positive for AMR gene: 
blaTEM 
blaCTX-
M-15 
blaSHV blaOXA qnrA qnrB qnrS aac(6’)-Ib aadA1 
Pig feces 25 10 (40.0) 0 1 (4.0) 0 1 (4.0) 0 6 (24.0) 1 (4.0) 17 (68.0) 
Pig carcasses 12 7 (58.33) 0 0 0 0 2 (16.7) 8 (66.7) 0 9 (75.0) 
Poultry feces 28 24 (85.71)
a
 0 0 0 3 (10.7) 0 1 (3.57) 2 (7.1) 20 (71.4) 
Poultry carcasses 12 10 (83.33)
a
 
2 
(16.67) 
0 0 3 (25.0) 0 3 (25.0) 0 7 (58.3) 
Total 77 51 (66.2) 2 (2.6) 1 (1.3) 0 7 (9.1) 2 (2.6) 18 (23.4) 3 (3.9) 53 (68.8) 
iucD 53 35 (66.0) 0 1 (1.89) 0 6 (11.3) 1 (1.89) 12 (22.6) 2(3.8) 37 (69.8) 
tsh 7 5 (71.4) 0 0 0 1 (9.7) 0 4 (57.1) 1(14.3) 6 (85.7) 
iucD:tsh 8 4 (50.0) 0 0 0 0 0 1 (12.5) 0 5 (62.5) 
iucD:papC 4 4 (100) 0 0 0 0 0 1 (25.0) 0 2 (50.0) 
iucD:cnf 2 0 0 0 0 0 0 0 0 0 
iucD:tsh:papC 3 3 (100) 2 (66.7) 0 0 0 1 (33.3) 0 0 3 (100) 
a
 P <0.05 for comparison of indicated group with all other groups. 
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Table VI1a. Association of ciprofloxacin-resistance and PQMR genes 
Source No. of -
resistant 
isolates 
No. (%) of ciprofloxacin -resistant isolates  
possessing PQMR gene: 
qnrA qnrB qnrS aac(6’)-Ib Nonea 
Pig feces 12  0 0 0 1 (8.3) 11 (91.6) 
Pig carcasses 5  0 1 (20.0)
b
 3 (60.0)
b
 0 2 (40.0) 
Poultry feces 27 3 (11.1) 0 1 (3.7) 2 (7.4) 21 (77.8) 
Poultry carcasses 5  2 (40.0)
c
 0 2 (40.0)
c
 0 2 (40.0) 
a
: No. (%) of CIP resistant isolates which are negative for all tested PQMR genes. 
b
: one CIP-resistant E. coli isolate from a pig carcass possessing both qnrB and qnrS genes. 
c
: one CIP-resistant E. coli isolate from a poultry carcass possessing both qnrA and qnrS genes. 
 
Table VIb. Association of ampicillin and streptomycin-resistance and AMR genes 
Source No. of 
ampicilli
n - 
resistant 
isolates 
No. (%) of ampicillin -resistant isolates  
possessing β-lactamase genes 
No. of 
streptom
ycin- 
resistant 
isolates 
No. (%) of 
streptomycin-
resistant isolates  
possessing 
resistance gene:  
blaTEM blaSHV blaOXA blaCTX-M15 None
a
 aadA1 None
b
 
Pig feces 25 10 (40.0) 1 (4.0) 0 0 14 (56.0) 24 17 (70.8) 7 (29.2) 
Pig carcasses 11 7 (63.6) 0 0 0 4 (36.4) 10 8 (80.0) 2 (20.0) 
Poultry feces 26 22 (84.6) 0 0 0 4 (15.4) 25 18 (72.0) 7 (28.0) 
Poultry carcasses 11 9 (81.8) 0 0 2 (18.1) 2 (18.1) 8 6 (75.0) 2 (25.0) 
AMR: antimicrobial resistance; AMP: ampicillin; STR: streptomycin. 
a
: No. (%) AMP-resistance isolates which are negative for all tested β-lactamase genes. 
b
: No. (%) STR-resistance isolates which are negative for aadA1 gene. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
  
 66 
 
To our knowledge, most studies have investigated the prevalence of ExPEC in retail 
meat (focusing mainly on poultry) and/or human isolates without regarding isolates 
from animal production (Johnson et al., 2005b, 2007a). This is the first study 
describing the potential ExPEC isolated from pigs and poultry at farms and in 
abattoirs in Vietnam. Our findings suggest correlations among strains isolated from 
pig and poultry feces and isolated from carcasses at abattoirs. 
In our study, 13.1% (328/2505) of strains from all sources were classified as 
potential ExPEC due to the possession of one or more virulent genes contributing to 
bacteria virulence and uropathogenesis in humans, including iucD, tsh, papC and cnf. 
For pig-feces isolates, low prevalence of iucD and tsh gene occurred in 6% 
(87/1460), and 2.5% (36/1460) respectively, whereas the occurrence of these genes 
varied among previous studies.  Schierack et al. reported the occurrence of iucD and 
tsh was 11.8% and 5.9% in E. coli isolated from a small group of piglets (Schierack 
et al., 2008). Cortes et al noted iucD gene was present in only one isolate (1/29) and 
tsh occurred in 24.1% (7/29) of E. coli isolates from pig farms (Cortes et al., 2010). 
Interestingly, our data showed the occurrence of cnf in pig-feces isolates at a very 
low prevalence (0.21%), which were not detected in healthy pigs in other countries 
(Cortes et al., 2010; Wu et al., 2007). However, the occurrence of papC in pig-feces 
isolates was lower than reported in other study (Jakobsen et al., 2010). The specific 
prevalence of each of the virulence genes in poultry-feces isolates were lower than 
reported in previous data (Cortes et al., 2010; Ewers et al., 2009). However, the 
frequency of tsh in poultry-feces isolates in our study was consistent with the 
prevalence of tsh among fecal poultry isolates in Brazil (Delicato et al.,  2002). 
The distribution of the four ExPEC virulence genes was significantly different 
among pigs and poultry.  All four virulence genes were detected among isolates from 
pigs but only three virulence genes were detected among poultry isolates. In contrast, 
a previous study of ExPEC isolates with the five virulence genes including papC, 
sfa/foc, afa/dra, kpsM, and iutA in retail meats found poultry possessing more 
virulence genes compared to pork (Johnson et al., 2005b). However, the prevalence 
of iucD, tsh and papC were respectively higher in poultry isolates than pig isolates. 
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Our findings support the hypothesis that ExPECs are more predominant in poultry 
than in pigs (Jakobsen et al, 2010, Cortes et al, 2010). 
ExPEC virulent factors were more common in poultry-carcass isolates (22%) than 
those from pig carcasses (15.6%), which is consistent with previous studies (Johnson 
et al., 2005b; Xia et al., 2011). A similar prevalence (20 to 21%) of ExPEC was 
reported in E. coli isolated from poultry meat (Johnson et al., 2003; Xia et al., 2011). 
Poultry has long been considered a source of E. coli strains with zoonotic potential 
(Bélanger et al., 2011), therefore, our observation that ExPEC are common in poultry 
meat support the hypothesis of retail meats as a source of pathogenic E. coli capable 
of infecting both animals and humans (Johnson, et al., 2005b). Among these farms 
and abattoirs which are  linked in the production chain, we found E. coli strains 
sharing the same virotypes including iucD and tsh in pigs and iucD, iucD:tsh and 
iucD:tsh:papC in poultry. These findings suggest that the E. coli in pig carcasses 
may originate from pigs on-farm and E. coli in poultry meat may originate from 
poultry on-farm due to cross contamination of fecal E. coli on carcasses during 
slaughter. 
In addition to prevalence data, our study provides novel information on the 
phylogenetic classification of potential ExPEC strains from pigs and poultry. 
According to our understanding, this is the first study related to the distribution of 
phylogenetic groups among ExPECs isolates from pig and poultry in Vietnam. The 
majority of potential ExPEC strains belonged to phylogroups A and B1. However, 
isolates from poultry feces were associated more frequently with group A whereas 
isolates from poultry carcasses were associated substantially with group B1. As 
indicated in comparison of virulence profiles of potential ExPEC strains from poultry 
and pigs, the virulence potential of ExPEC strains from poultry was further supported 
by phylogenetic analysis of these strains. Our data show the existence of potential 
ExPEC strains belonging to phylogroup B2 (1.4%) in poultry feces and the 
significantly higher frequency of phylo D- ExPEC strains in poultry feces (19.1%) 
versus the frequency in pigs feces (3.8%). Studies in US demonstrated that virulent 
extraintestinal E. coli strains originated mostly from phylogenetic group B2, and to a 
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lesser extent from group D ( Johnson et al., 2007a). Compared to other studies, the 
prevalence of potential ExPEC strains belonged to phylogroup B2 in poultry in 
Vietnam was lower than those from European countries (Cortes et al., 2010; Giufre 
et al., 2012). However, our data are consistent with previous studies in terms of the 
predominant prevalence of phylo D- ExPEC strains in poultry versus the prevalence 
in pigs (Cortes et al., 2010). These findings have shown the occurrence of potential 
pathogenic E.coli strains in food animals in Vietnam, particularly in poultry, which 
may be associated with clinical strains in humans.  
Our analysis of 83 potential ExPEC isolates from pig carcasses and poultry carcasses 
revealed a small difference between the proportions of potential ExPEC belonging to 
group D in poultry strains (9.1%) and in pig strains (7.7%). This finding is likely 
inconsistent with the higher frequency of phylo D- ExPEC isolates in poultry implied 
that poultry might deserve greater attention than pigs, with respect to the possibility 
of transmission of ExPEC (Johnson et al., 2005b; Xia et al., 2011). 
In our study, the phylogroups A and B1 E.coli strains, traditionally belonging to 
commensal strains in humans, possessed more investigated virulence genes than 
phylogroups B2 and D isolates. All investigated virulence genes were detected 
among phylogroups B1 isolates whereas only iucD gene was detected among isolates 
belonged to phylogroups B2. The cnf gene, which is involved in UTI in humans ( 
Johnson et al., 1991), was not present in phylogroups B2 and D isolates. These 
findings were not in accordance with other studies in terms of the dominance of 
ExPEC virulence genes in B2 and D isolates (Jakobsen et al, 2010, Duriez et al., 
2001). Thus, the virulence genes profiles may vary due to a limitation on the number 
of investigated virulence genes or the specificity of these primers used in our study 
In the present study, most E.coli isolates that carried iucD:tsh  belonged to group A 
and B1, whereas these strains carried iucD:papC were more frequently associated 
with group D. Those strains that carried the iucD:tsh:papC were associated 
positively with group A and B1 but negatively associated with group B2 and D. 
Thus, phylogroup A and B1 isolates should not be underestimated when assessing 
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their potential impact on human disease. Also, based on a poultry infection model, 
Ewers et al. demonstrated that pathogenicity of commensal poultry isolates might 
result in a source of strains capable of causing extraintestinal infections (Ewers et al., 
2009).  
Our results showed that multidrug resistance is widespread among these potential 
ExPEC isolates from pigs and poultry, not corresponding to geographical and/or 
sanitary conditions at farms and abattoirs. There were 95% and 94% isolates from 
pigs and poultry, respectively that showed resistance to four or more classes of 
antimicrobials. These results were consistent with the high multidrug resistance in 
E.coli from retail meat reported in a previous study in Vietnam (Van et al., 2008). 
The findings might be explained by the widespread use of antimicrobials, often 
without prescription, in animal production in Vietnam. Therefore, it is tempting to 
suggest that this is a primary source of selection for resistant organisms. 
Overall, our findings showed a widespread resistance to quinolones and 
fluoroquinolones among E. coli from pigs and poultry. E. coli isolates from poultry 
were more significantly associated with ciprofloxacin and nalidixic acid resistance 
than those from pigs (P<0.05). These findings were in broad agreement with other 
studies on high prevalence of resistance to ciprofloxacin among E. coli of pig and 
poultry origin reported in other Asia countries such as China and Korea (Tang et al., 
2011; Yang et al., 2004; Lee et al., 2005). In contrast, resistance to ciprofloxacin in 
E. coli isolates from poultry was reported as either low or non-existent in United 
States, Canada and some European countries (Gyles, 2008), perhaps due to restricted 
use of fluoroquinolones in animal husbandry in these countries. For instance, use of 
fluoroquinolones were not permitted in pigs in Canada, thus E. coli isolated from this 
source showed very little resistance to these antimicrobials (Boerlin et al., 2005). 
Fluoroquinolones are critically important for treating serious infections in humans, 
such as diarrhea in children (Nguyen et al., 2005). Therefore, the likelihood that 
resistance to fluoroquinolones in E. coli was induced by the use of these 
antimicrobials in food animals is a major public health concern in Vietnam.  
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Remarkably, E. coli isolates from poultry feces and carcasses displayed a significant 
association of resistance of nalidixic acid and ciprofloxacin, at the rate of 89.4% and 
61.9% and 80.9% and 38.1% respectively. The associations of nalidixic acid and 
ciprofloxacin resistance were also observed in E. coli and ExPEC isolated from 
poultry meat in US (Johnson et al., 2005b). This might be explained due to 
contamination of animal carcasses with the host’s fecal flora during slaughter and 
processing and with use of antimicrobial agents in food-animal production. Likewise, 
the associations of nalidixic acid and ciprofloxacin resistance with poultry and pigs 
correspond with the approved veterinary use of fluoroquinolones in Vietnam.  
In this study, comparison of the resistance phenotypes of the potential ExPEC strains 
isolated from carcasses with those from pigs and poultry feces revealed that abattoir 
and farm isolates shared the major resistance patterns. The presence of overlapping 
resistance phenotypes between E. coli isolates from retail meat and farms has been 
previously described (Jacobsen et al, 2010). Strikingly, in this study, we found one 
ExPEC isolate from poultry feces and one isolate from poultry carcasses shared the 
same phylo-virotype D-iucD, and the same multi-resistance pattern of ten 
antimicrobials. The finding of ExPEC strains which share the same virotypes, 
phylotypes and antimicrobial resistance profiles among farms and abattoirs indicate 
the risk of contamination of potentially pathogenic E. coli from feces to carcasses 
during slaughter. 
As observed in previous studies (Do et al., 2006; Van et al., 2008; Yang et al., 2004), 
most E. coli isolates from pigs and poultry were resistant to tetracycline, 
streptomycin, amoxicillin, and trimethoprim/sulfamethoxazole. It is important to note 
that the two latter antimicrobials are frequently prescribed for treatment of UTIs in 
humans (Talan et al., 2008). Also, more than 70% isolates from all sources were 
resistant to chloramphenicol. In fact, chloramphenicol is prohibited for use in food 
animals and chloramphenicol residue is rarely detected in retail food in Vietnam 
(http://www.cddep.org/sites/cddep.org/files/publication_files/VN_Report_web_1.pdf
?issuusl=ignore). Thus, the high prevalence of chloramphenicol resistance might be 
caused by the co-selection pressure due to use of other antimicrobials in the phenicol 
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group, such as florfenicol, in animal production (Harada et al., 2006).  In the other 
way, the high prevalence of chloramphenicol -resistance might be caused by the 
persistence of chloramphenicol -resistant genes such as the cmlA gene located on 
transferable plasmids in linkage with other genes encoding resistance to 
antimicrobials that are currently approved for use in food animals (Bischoff et al, 
2005). It is noteworthy that multi-resistance to ampicillin, chloramphenicol, and 
trimethoprim-sulphamethoxazole was also reported in diarrheagenic E. coli strains 
isolated from children in Vietnam (Nguyen et al., 2005). Taken together, these results 
suggest food animals might be a reservoir, and consequently, meats might be a 
vehicle for transmitting antimicrobial resistant E. coli strains which may cause 
infections in humans. 
In our study, most isolates were susceptible to antimicrobials that belonged to the 
third-generation cephalosporin class, including cefoxitin, ceftiofur and ceftriaxone. 
Resistance to cefoxitin was detected in only one isolate from pig carcasses. 
Interestingly, resistance to ceftiofur and ceftriaxone and the presence of blaCTX-M-15, 
encoding the most common ESBL associated with human ExPEC from UTI, was 
found in poultry E. coli isolates recovered from Mac Conkey agar containing 
ceftiofur. In terms of public health impact, this observation suggested the risk of 
development and selection for extended spectrum-lactamases (ESBLs) that could be 
potentially transferred through the food chain in Vietnam. 
On comparison of VFs and the antimicrobial resistance phenotype of our ExPEC 
isolates, we observed significant correlations. Among pig isolates from farms and 
abattoirs, these included correlations between nalidixic acid and ciprofloxacin 
resistance and possession of iucD; and ampicillin, chloramphenicol, and 
trimethoprim-sulphamethoxazole, and tetracycline resistance and possession of iucD 
or tsh (Annex 3). Among poultry isolates from farms and abattoirs, there were 
correlations between nalidixic acid and ciprofloxacin resistance and possession of 
iucD; and ampicillin, trimethoprim-sulphamethoxazole, and tetracycline resistance 
and possession of iucD or iucD:tsh. Correlations between VF and resistance profiles 
were reported among ExPEC isolates from poultry and humans, for 
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example,virulence genes were positively associated with multidrug resistance, 
including ireA, ibeA, fyuA, cvaC, iss, iutA, iha, and afa ( Johnson et al., 2012). This is 
supportive of previous work suggesting that certain subsets of ExPEC are capable of 
zoonotic transfer (Johnson et al., 2003a, 2007). Nevertheless, poultry and pig isolates 
differed significantly in their assignments to phylogenetic groups and antimicrobial 
resistance phenotypes, with phylogroup A being more prevalent among nalidixic acid 
and ciprofloxacin- resistance pig isolates than among poultry isolates, whereas 
phylogroup D was associated with nalidixic acid and ciprofloxacin- resistance 
isolates of poultry origin (Cortes et al., 2010. This finding strengthens the hypothesis 
that poultry might be a source for at least ciprofloxacin-resistant group D strains 
which are considered as potential clinical strains in humans. 
In our study, the presence of the AMR genes in correlation with antimicrobial 
resistance phenotype was investigated with 77 E. coli isolates which showed the 
highest degree of antimicrobial resistance. Although quinolone resistance results 
mostly from chromosomal mutations in Enterobacteriaceae, it may also be caused by 
plasmid-mediated genes. Several reports had shown a low prevalence of the qnr 
genes  in food-producing animals (Yue et al., 2008). In our study, the PCR results 
revealed that 26.2% quinolone-resistant isolates in pig and in poultry possessed a qnr 
gene. However, 62.5% isolates in pig and poultry which possessed qnr gene were 
susceptible or intermediate with nalidixic acid and ciprofloxacin. Since qnr was 
found in both ciprofloxacin-susceptible and -resistant E. coli strains, qnr genes may 
promote further selection from low- to high-level resistance when quinolones are 
used (Robicsek et al, 2006). Our findings support the previous studies which showed 
PMQR determinants confer low-level resistance to quinolones and facilitate selection 
of higher level quinolone resistant bacteria (Tran et al., 2005; Jacoby et al., 2006,  
Yue et al, 2008). However, further studies are necessary to determine the factors 
contributing to the nalidixic acid and ciprofloxacinresistance phenotype in potential 
ExPEC isolates in our study.  
In the present study, the simultaneous presence of qnrA and qnrS was detected in two 
strains from poultry carcasses, however only one strain showed full resistance to 
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nalidixic acid and ciprofloxacinwhereas the other strain was intermediate with 
nalidixic acid and susceptible with ciprofloxacin. The co-existence of qnrB and qnrS 
genes was also found in one nalidixic acid and ciprofloxacin-resistant E. coli strain 
from a pig carcass. In contrast, the only one qnrB-positive E. coli strain from pig 
carcasses was susceptible to both nalidixic acid and ciprofloxacin. These results 
suggest that the combination of these qnr genes did not have any additional effect on 
resistance to nalidixic acid. 
Our data show the high prevalence of qnr genes in E. coli from food production 
animals, in particular in poultry meat and pork. In a previous study, a high 
prevalence of qnr genes, in particular the qnrS gene was observed in hospitalized 
patient E. coli strains as well as in E. coli community strains in Ho Chi Minh City, 
Vietnam (Le et al., 2009). These findings together suggest a potential public health 
concern about the spread of genetic resistance elements from food animal products to 
humans through the food chainin Vietnam. In addition, class 1 integrons are known 
to be associated with multiple-drug resistance among Gram-negative bacteria, and 
specifically have been shown to be associated with the presence of qnr gene which 
provides low-level quinolone resistance (Wang et al, 2003). The occurrence of qnr 
genes in fluoroquinolone-resistant E. coli isolates suggests the possibility that qnr 
genes which are present in some of our pig and poultry strains might be associated 
with the presence of class 1 integrons. 
A variant of the aac(6’)-Ib gene, the aac(6’)-Ib-cr has been indicated as the gene 
encoding for enzyme acetylates ciprofloxacin and norfloxacin (Robicsek et al.,  
2006a). The co-transmission of qnr with aac(6’)-Ib-cr genes which speeds up the 
formation of multidrug resistance in E. coli has been previously reported in China 
(Yue et al., 2008). In our study, aac(6’)-Ib gene was present in only one isolate from 
pig feces and two isolates from poultry feces. The findings showed that currently 
there is no significant association between aac(6’)-Ib gene and the quinolone 
resistance in pig and poultry farms in Vietnam. Our findings also showed that there is 
no association between aac(6’)-Ib genes and  other antimicrobial resistant genes. 
However, the presence of the potential ExPEC strains harbouring the aac(6’)-Ib 
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might reflect a steady increase due to the use of quinolone and kanamycin on pig and 
poultry farms, that might gradually have generated selection pressure for these 
resistant strains.  
The high correlation between genotype and phenotype of ExPEC strains with respect 
to resistance to ampicillin and streptomycin indicated that the resistance genes 
investigated had important roles in conferring resistance among the isolates. Our 
findings showed that blaTEM was associated significantly with potential ExPEC 
isolates from poultry feces and poultry carcasses (P<0.05). The gene encoding 
resistance to streptomycin, aadA1, was also widely distributed at high frequency in 
pigs and poultry isolates. These results were consistent with previous studies which 
reported that blaTEM and aadA1 were the predominant genes associated with 
ampicillin and streptomycin resistance, respectively, in animal strains (Tang et al, 
2011, Van et al, 2008).  
To our knowledge, this study is the first to report on the occurrence of ESBL-
producing isolates in pig feces and poultry meat in Vietnam. Previously, blaCTX-M-15, 
the most common ESBL gene among human ExPEC strains isolated from both UTI 
and sepsis, had been detected in Shigella spp in Vietnam (Nguyen et al., 2010). In 
our study, the blaCTX-M-15 gene was detected in poultry carcass E. coli isolates 
recovered from Mac Conkey agar containing ceftiofur. Interestingly, associations 
between virulence genes and antimicrobial resistance genes were observed in our 
study. For instance, blaTEM was observed in association with iucD among pig and 
poultry-feces isolates. 
Interestingly, it was observed that compared to other sources, E. coli in poultry 
showed a higher frequency of antimicrobial resistance, and of presence of 
antimicrobial resistance genes and virulence genes. Overall, it could be concluded 
that poultry meat is an important risk-associated food source in terms of 
antimicrobial resistance and virulence potential. The spread of antimicrobial agents 
given to poultry might be the reason for high rates of resistance and overcrowding in 
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poultry husbandry may contribute to the spread of antimicrobial and virulence genes 
between populations.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
  
  
Our results confirm those of several other studies that meats, particularly poultry 
meat, and to a lesser extent, pork, might be a vehicle for transmission of potentially 
zoonotic ExPEC strains. This study suggests that ExPEC in pig and poultry carcasses 
may originate from pigs and poultry on-farm, respectively, due to fecal 
contamination during slaughter. This study also shows the low prevalence of STEC 
and EPEC in pigs and poultry, which need to be constantly monitored to determine 
the potential risks of these food-borne pathogenic E. coli in Vietnam. Phylogroup 
distribution and virulence profiles suggest that ExPEC isolates from poultry are 
potentially more pathogenic for humans than those from pigs. The occurrence of 
phylogroup D isolates in pigs and poultry and, particularly, the presence of group B2 
poultry-isolates, implicate the emergence of ExPEC strains which may be related to 
clinical human ExPEC isolates.  
Moreover, this study shows that antimicrobial resistance is widespread among E. coli 
from pigs and poultry in Vietnam, not corresponding to geographical areas. 
Additionally, our results provide evidence for the possibility of contamination of 
AMR strains from animals to carcasses during slaughter. The frequencies of 
resistances to several antimicrobials, and several relevant resistance genes, and the 
occurence of multidrug resistant ExPEC have been found to be substantially high in 
pigs and poultry. This indicates that a lack of control of antimicrobial use in food-
producing animals in Vietnam has resulted in the emergence and dissemination of 
multidrug resistant isolates. The finding that PMQR and ESBL genes were present 
among E. coli isolates on farms and also in abattoirs, indicate a potential public 
health concern that food animals might be a reservoir for the dissemination of these 
genes from food animals to humans through the food chain. Further investigation is 
required to assess the risk of zoonotic transmission via the food chain. Based on the 
results of this study, it is suggested that the widespread use of quinolones and/or 
penicillin to food-production animals might select for β-lactamase and PMQR strains 
in animals.  
Although the prevalence of ExPEC virulence genes is not very high in E. coli isolates 
on the populations of pigs and poultry on-farm, their presence in the microflora of 
  
health animals and the association between virulence genes and antimicrobial 
resistance genes is a major public health problem. The results of prevalence of 
virulence gene iucD and its association with β-lactamase isolates are of major 
concern, considering the likelihood that these two genes are encoded on the same 
plasmid. Thus, future work should include further study of the genomic profile of 
strains of E. coli as well as of the genetic background of antimicrobial resistance. 
Because this study relied on a limited number of virulence and AMR genes, the 
prevalence of potential ExPEC strains and AMR strains may be underestimated. 
Further comprehensive studies with appropriate epidemiological and genetic tools 
are needed to elucidate more fully the prevalence of ExPEC and AMR strains in food 
producing animals in Vietnam. In conclusion, demonstration of the occurrence of 
ExPEC and AMR strains in pigs and poultry on farms and in abattoirs in Vietnam, 
underlines the importance of restricting antimicrobial use and improving sanitary 
conditions during slaughter, in order to minimize public health risks associated with 
animal food in Vietnam. 
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ANNEXES 
  
i 
 
Annex 1 List of samples of poultry feces and carcasses collected in Vietnam 
No. Farm  
Number of fecal samples 
No. Abattoir 
Number of carcass 
samples 
Total Code Total Code 
1. Poultry farm in Bac Giang province 8 FC1-FC8 1. Phuc Thinh Company, Hanoi 3 CM1-CM3 
2. 
Poultry farm 1 in Thai Nguyên 
province 
4 FC9-FC12 
2. Phuc Thinh Company, Hanoi 3 CM4-CM6 
3. 
Poultry farm 2 in Thai Nguyên 
province 
4 FC13-FC16 
 
Poultry farm 2 in Thai Nguyên 
province 
8 FC17-FC24 3. Phuc Thinh Company, Hanoi 3 CM7-CM9 
4. Poultry farm 3 in Thai Nguyên 12 FC25-FC36 4. Minh Hien Company, Hanoi 9 CM10-CM18 
5. Poultry farm in Hoa Binh province 15 FC37-FC51   
  
 Total 51 
 
  18 
 
 
  
ii 
 
Annex 2 List of samples of pig feces and pig carcasses collected in Vietnam 
 
No. 
 
Farm 
Number of fecal samples 
No. Abattoir 
Number of carcass samples 
Total Code Total Code 
1. Pig farm 1 in Son Tay town, Hanoi 4 FP1-FP4 1. 
Foodex Limited 
Company, Hanoi 
2 PM1-PM2 
2. 
Pig farm 2 in Son Tay town, Hanoi 
(Herd 1) 
5 FP5-FP9 2. 
Foodex Limited 
Company, Hanoi 
4 PM3-PM6 
Pig farm 2 in Son Tay town, Hanoi 
(Herd 2) 
7 FP10-FP16   
  
Pig farm 2 in Son Tay town, Hanoi 
(Herd 3) 
8 FP17-FP24   
  
3. Pig farm 3 in Son Tay town, Hanoi 2 FP25-FP26   
  
4. Pig farm in Ninh Binh province 4 FP27-FP30 3. Abattoir 1, Hanoi 1 PM11 
5. Pig farm 1 in Thai Binh province 4 FP31-FP34 4. Abattoir 2, Hanoi 2 PM14-PM15 
6. Pig farm in Thanh Oai district, Hanoi 2 FP35-FP36 5. Abattoir 3, Hanoi 1 PM7 
7. 
 
Pig farm 2 in Thai Binh province 2 FP37-FP38 
6. Abattoir 4, Hanoi 3 PM8, PM12-PM13 
7. Abattoir 5, Hanoi 2 PM9-PM10 
8. Pig farm in My Duc district, Hanoi 10 FP39-FP48 8. Abattoir 1, Hanoi 2 PM16-PM17 
9. Pig farm in Bac Giang province 4 FP49-FP52 9. Abattoir 2, Hanoi 2 PM18-PM19 
10. Pig farm in Bac Ninh province 6 FP53-FP58 10. Abattoir 3, Hanoi 2 PM20-PM21 
 Total 58 
 
  21 
 
  
Annex 3. Association of virulence genes and antimicrobial resistance among 132 potential ExPEC isolates 
Source/ 
Virotype 
No. of 
isolates 
(n) 
Percentage of resistance isolates  
(1) (2) (3) (4) (5) (6) (7) 
AM
P 
AM
C 
TIO FOX CRO NAL CIP 
A
M
K 
GE
N 
KAN STR SXT CHL FIS TET 
Pig feces 40 92.5 10 0 2.5 0 47.5 30 0 45 27.5 80 70 70 92.5 100 
iucD 21 95.2 14.3 0 4.76 0 66.7 47.6 0 52.4 42.9 85.7 76.2 76.2 95.2 100 
tsh 7 85.7 14.3 0 0 0 0 0 0 28.6 28.6 42.9 85.7 71.4 100 100 
iucD:tsh 8 87.5 0 0 0 0 37.5 0 0 25 0 87.5 50 50 87.5 100 
iucD:papC 1 100 0 0 0 0 0 0 0 100 0 100 0 100 0 100 
iucD:tsh:papC 1 100 0 0 0 0 0 0 0 0 0 100 0 0 100 100 
iucD:cnf 1 100 0 0 0 0 100 100 0 100 0 100 100 100 100 100 
Pig carcass 24 91.7 12.5 0 4.17 0 45.8 25 0 29.2 25 62.5 79.2 79.2 75 100 
iucD 13 84.6 0 0 0 0 61.5 30.8 0 30.8 15.4 53.8 61.5 76.9 61.5 100 
tsh 7 100 28.6 0 0 0 42.9 28.6 0 0 28.6 71.4 100 85.7 85.7 100 
iucD:tsh 1 100 0 0 0 0 0 0 0 0 0 0 100 0 100 100 
iucD:papC 2 100 0 0 50 0 0 0 0 100 50 100 100 100 100 100 
iucD:tsh:papC 1 100 100 0 0 0 0 0 0 100 100 100 100 100 100 100 
Poultry feces 47 91.5 23.4 0 0 0 89.4 80.9 2.1 66 74.5 83 97.9 93.6 97.9 100 
iucD 34 91.2 14.7 0 0 0 91.2 85.3 0 70.6 76.5 88.2 97.1 91.2 97.1 100 
tsh 4 100 75 0 0 0 75 50 0 75 75 25 100 100 100 100 
iucD:tsh 6 83.3 33.3 0 0 0 100 83.3 0 33.3 66.7 83.3 100 100 100 100 
iucD:papC 2 100 0 0 0 0 100 100 50 100 100 100 100 100 100 100 
tsh:papC 1 100 100 0 0 0 0 0 0 0 0 100 100 100 100 100 
Poultry carcass 21 95.2 14.3 9.52 0 9.52 66.7 38.1 0 38.1 57.1 71.4 100 81 100 100 
iucD 14 92.9 7.14 0 0 0 78.6 50 0 50 57.1 85.7 100 78.6 100 100 
iucD:tsh 3 100 0 0 0 0 33.3 33.3 0 33.3 0 33.3 100 66.7 100 100 
iucD:papC 2 100 100 0 0 0 0 0 0 0 100 0 100 100 100 100 
iucD:tsh:papC 2 100 0 100 0 100 100 0 0 0 100 100 100 100 100 100 
  
iv 
 
Annex 4. Association of phylotypes and antimicrobial resistance among 132 potential ExPEC isolates 
Source/ 
Phylotype 
No. of 
isolates 
(n) 
Percentage of resistance isolates 
(1) (2) (3) (4) (5) (6) (7) 
AM
P 
AMC TIO FOX CRO NAL CIP 
AM
K 
GE
N 
KA
N 
STR SXT CHL FIS TET 
Pig feces 40 92.5 10 0 2.5 0 47.5 30 0 45 27.5 80 70 70 92.5 100 
A 24 87.5 12.5 0 4.2 0 33.3 29.2 0 41.7 33.3 70.8 66.7 75 87.5 100 
B1 13 100 7.69 0 0 0 61.5 30.8 0 53.8 15.4 92.3 69.2 61.5 100 100 
D 3 100 0 0 0 0 100 33.3 0 66.7 33.3 100 100 33.3 100 100 
Pig carcass 24 91.7 12.5 0 4.17 0 45.8 25 0 29.2 25 62.5 79.2 79.2 75 100 
A 15 93.3 20 0 6.67 0 40 26.7 0 26.7 26.7 60 93.3 73.3 86.7 100 
B1 7 85.7 0 0 0 0 57.1 14.3 0 14.3 0 57.1 57.1 85.7 57.1 100 
D 2 100 0 0 0 0 50 50 0 100 100 100 50 100 50 100 
Poultry feces 47 91.5 23.4 0 0 0 89.4 80.9 2.1 66 74.5 83 97.9 93.6 97.9 100 
A 15 93.3 46.7 0 0 0 80 73.3 0 66.7 66.7 80 100 100 93.3 100 
B1 15 93.3 13.3 0 0 0 93.3 93.3 0 53.3 73.3 86.7 93.3 86.7 100 100 
D 15 86.7 6.7 0 0 0 93.3 80 6.7 80 86.7 80 100 93.3 100 100 
B2 2 100 50 0 0 0 100 100 0 100 50 100 100 100 100 100 
Poultry carcass 21 95.2 14.3 9.52 0 9.52 66.7 38.1 0 38.1 57.1 71.4 100 81 100 100 
A 4 75 0 0 0 0 100 25 0 50 75 75 100 75 100 100 
B1 13 100 7.7 15.4 0 15.4 61.5 38.5 0 30.8 46.2 76.9 100 76.9 100 100 
D 4 100 50 0 0 0 50 50 0 50 75 50 100 100 100 100 
  
v 
 
Annex 5. Association of phylotypes and antimicrobial resistance genes among 77 potential ExPEC isolates from 
different sources 
Source/ 
Phylotype 
Total
a
 
(n) 
 No. (%) of E.coli isolates
b
 
blaTEM blaCTX-M-15 blaSHV blaOXA qnrA qnrB qnrS aac(6’)-Ib aadA1 
Pig feces 25 10 (40.0) 0 1 (4.0) 0 1 (4.0) 0 6 (24.0) 1 (4.0) 17 (68.0) 
A 13 6 (46.2) 0 0 0 1 (7.7) 0 3 (32.1) 1 (7.7) 10 (76.9) 
B1 9 3 (33.3) 0 1 (11.1) 0 0 0 2 (22.2) 0 4 (44.4) 
D 3 1 (33.3) 0 0 0 0 0 1 (33.3) 0 3 (100) 
Pig carcasses 12 7 (58.3) 0 0 0 0 2 (16.7) 8 (66.7) 0 9 (75.0) 
A 7 5 (71.4) 0 0 0 0 2 (28.6) 5 (71.4) 0 6 (85.7) 
B1 3 0 0 0 0 0 0 1 (33.3) 0 2 (66.7) 
D 2 2 (100) 0 0 0 0 0 2 (100) 0 1 (50.0) 
Poultry feces 28 24 (85.71) 0 0 0 3 (10.7) 0 1 (3.57) 2 (7.1) 20 (71.4) 
A 7 5 (71.4) 0 0 0 1 (14.3) 0 0 0 6 (85.7) 
B1 10 8 (80.0) 0 0 0 2 (20.0) 0 0 2 (20.0) 5 (50.0) 
D 9 9 (100) 0 0 0 0 0 0 0 8 (88.9) 
B2 2 2 (100) 0 0 0 0 0 1 (50.0) 0 1 (50.0) 
Poultry carcasses 12 10 (83.33) 2 (16.67) 0 0 3 (25.0) 0 3 (25.0) 0 7 (58.3) 
A 3 2 (66.7) 0 0 0 1 (33.3) 0 1 (33.3) 0 2 (66.7) 
B1 5 5 (100) 2 (40.0) 0 0 2 (40.0) 0 2 (40.0) 0 3 (60.0) 
D 4 3 (75.0) 0 0 0 0 0 0 0 2 (50.0) 
Total 77 51 (66.2) 2 (2.6) 1 (1.3) 0 7 (9.1) 2 (2.6) 18 (23.4) 3 (3.9) 53 (68.8) 
a
: Number of potential ExPEC isolates from different sources.  
b
: Percentages of ExPEC isolates which are positive with the AMR gene. 
  
 
 
 
